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                                                                      “学而不思则罔，思而不学则殆。” 
                                                                                                                     （孔子） 
 
“Learning without thought is labour lost; thought without learning is perilous.” 
                                                                                                                   (Confucius) 
  
Abstract 
Background: Sickness absence is a frequent recommendation in Swedish health care. Yet, 
research on future health outcomes of being sickness absent is sparse. Mental disorders are 
one of the most common diagnostic groups for sickness absence. Knowledge on psychiatric 
morbidity and suicidal behaviour following sickness absence is therefore of special interest. 
Exploring this should be done by using different sick-leave measures and by exploring 
differences over time, for instance, in relation to changes of social insurance regulations. The 
aim of this thesis was to investigate different aspects of the associations between sickness 
absence and subsequent morbidity, suicide attempt, and suicide.  
Methods: Four population-based longitudinal cohort studies were conducted, using 
nationwide Swedish register data. All individuals aged 16-64 years who lived in Sweden as 
on 31 December 2004 (n=4 923 404), and all individuals aged 20-64 years who lived in 
Sweden as on 31 December 2005 or 2008 (n=4 477 678; n=4 500 400), respectively, and who 
were not on old-age or disability pension were followed up for six years in Study I and for 
two years in Study IV. In Study II, all such individuals aged 16-64 years who lived in 
Sweden as on 31 December 2004 and had in- or specialised outpatient care due to depressive 
disorders in 2005 were included (n=21 096). In Study III, 4209 individuals aged 22-65 years 
who committed suicide in 2007-2010 were included. In all the studies, information on socio-
demographics, health care, medication, sickness absence, disability pension, and death was 
linked at individual level from registers held by the Social Insurance Agency, the National 
Board of Health and Welfare, and Statistics Sweden. Cox regression analyses were performed 
to estimate associations between sickness absence and inpatient care and suicidal behaviour 
(Study I, II, and IV). A group-based trajectory method was applied to identify sickness 
absence/disability pension trajectories in the five years before the suicide (Study III).  
Results: Individuals who had been sickness absent, measured as incidence all-cause and 
diagnosis-specific sickness absence and sick-leave duration, showed a higher risk of 
subsequent suicide attempt and suicide compared to those without sickness absence (Study I 
and IV). Higher risks of suicidal behaviour associated with all-cause and diagnoses-specific 
sick-leave incidence and sick-leave duration were also observed among patients with 
depressive disorders (Study II). Among patients with depressive disorders and not on 
disability pension, those who had one or more incident sick-leave spells or had been full-time 
sickness absent had higher hazard ratios of suicide attempt in the following five years than 
those with no sickness absence (Study II). Individuals on sickness absence due to common 
mental or musculoskeletal diagnoses or with long-term sickness absence (>180 days) in 2009 
had higher hazard ratios of subsequent inpatient care due to somatic disorders compared to 
those on such sickness absence in 2006 (i.e. before the regulatory change in 2008) (Study 
IV). Among those who committed suicide, five different previous sickness absence/disability 
pension trajectories were identified (Study III). Almost half of the suicide victims had had 
constantly low levels of sickness absence/disability pension, while 30% had constantly high 
such levels in the five years before the suicide. The trajectories were characterised by 
differences in socio-demographic and health care factors.   
Conclusions: Sickness absence was a risk marker for suicidal behaviour, irrespective of 
sick-leave diagnoses, both for women and men in the general population and for patients 
with depressive disorders. In addition, incident mental or somatic sickness absence and long-
term sickness absence after the regulatory change in 2008 might be associated with a higher 
medical severity than such sickness absence before the change. More knowledge is warranted 
on such associations as bases for preventive actions.  
  
Svensk sammanfattning 
Bakgrund: Sjukfrånvaro är en vanlig ordination inom svensk hälso- och sjukvård. Trots 
detta är den vetenskapliga kunskapen om samband mellan sjukfrånvaro och framtida 
hälsosituation synnerligen begränsad. Då den vanligaste diagnosgruppen för längre 
sjukskrivning är psykiska diagnoser, finns det anledning att särskilt studera samband mellan 
sådan sjukskrivning och senare psykiska besvär och självmordsbeteende. Studier om detta 
behövs där olika aspekter, inklusive sjuklighet och förändringar av socialförsäkringen 
beaktas, baserade på olika sjukfrånvaromått. Syftet med avhandlingen var att få ytterligare 
kunskap om eventuella samband mellan att vara sjukskriven och framtida sjuklighet, 
självmordsförsök och självmord. 
Metod: Fyra populationsbaserade longitudinella kohortstudier genomfördes med hjälp av 
rikstäckande svenska registerdata. Alla personer som var 16-64 år gamla och som bodde i 
Sverige den 31/12 2004 (n=4 923 404) respektive alla personer som var 20-64 år gamla och 
som bodde i Sverige den 31/12 2005 eller 2008 (n=4 477 678; n=4 500 400) och som inte 
hade ålderspension eller sjuk- eller aktivitetsersättning följdes upp i studie I och IV. I studie II 
inkluderades samtliga personer som var 16-64 år gamla och bodde i Sverige 31/12 2004 och 
som haft sluten- eller specialiserad öppenvård på grund av depression under år 2005 
(n=21 096). I studie III inkluderades de 4209 personer, som när de var 22-65 år gamla begått 
självmord under 2007-2010 i Sverige. Information om sociodemografiska faktorer, hälso- och 
sjukvård, medicinering, sjukfrånvaro, sjuk- och aktivitetsersättning och död hämtades från 
registerdata från Försäkringskassan, Socialstyrelsen och Statistiska centralbyrån. Cox 
regressionsanalyser utfördes för att beräkna samband mellan sjukfrånvaro och slutenvård och 
självmordsbeteende (studie I, II, IV). I studie III användes en gruppbaserad analysmetod för 
att identifiera mönster av tidigare sjukfrånvaro/sjuk- och aktivitetsersättning. 
Resultat: De som haft ett nytt sjukskrivningsfall, generellt respektive i specifika diagnoser 
samt haft längre sådana fall hade en högre risk för senare självmordsförsök respektive 
självmord jämfört med dem som inte hade varit sjukskrivna (studie I och IV). Motsvarande 
högre risk bland sjukskrivna fanns även i studien där endast patienter med depression 
inkluderades (studie II). Personer som varit sjukskrivna i psykiska eller muskuloskeletala 
diagnoser eller varit sjukskrivna >180 dagar under 2009 hade högre hazard ratio av 
efterföljande slutenvård på grund av somatiska sjukdomar jämfört med dem som haft 
motsvarande sjukfrånvaro under 2006 (dvs. före införandet av nya socialförsäkringsregler år 
2008) (studie IV). Bland dem som begick självmord identifierades fem olika mönster av 
tidigare sjukfrånvaro/sjuk- och aktivitetsersättning (studie III). Nästan hälften av dem som 
begått självmord hade konstant låga nivåer av sjukfrånvaro/sjuk- och aktivitetsersättning 
under de fem föregående åren, medan 30 % hade haft konstant höga sådana nivåer. De olika 
mönstren karakteriserades av specifika sociodemografiska och sjukvårdsfaktorer. 
Slutsatser: Sjukfrånvaro var en riskmarkör för senare självmordsbeteende, oberoende av 
sjukfrånvarodiagnos, såväl bland kvinnor som bland män. Detta gällde hela befolkningen och 
mer specifikt bland patienter med depression. Dessutom var incident sjukfrånvaro i psykiska 
och somatiska diagnoser och lång sjukfrånvaro efter införandet av nya socialförsäkringsregler 
associerade med senare sjukhusvistelse (och därmed ev. med mer allvarlig sjuklighet) än 
sjukfrånvaro innan dess införande. Mer kunskap om detta behövs för att kunna vidtaga 
förebyggande åtgärder. 
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1 Introduction 
Sickness absence is to date a common recommendation in health care (1). In Sweden, the 
social insurance system provides financial compensation for lost income due to work 
incapacity caused by a disease or injury. In the past 20 years, concern about the occurrence of 
sickness absence has been expressed in several European countries as it potentially affects the 
sick-listed individuals and their families, employers, and the society at large (1). In Sweden, 
sickness absence has resulted in considerable costs for the government. In 2014, sickness 
benefits paid by the Swedish Social Insurance Agency (SIA) summed up to SEK 27.7 billion 
(2). Moreover, sickness absence may be associated with both positive and negative 
consequences on a person's physical, mental, and social circumstances (3). Long periods of 
sickness absence might not only be a marker of the severity of the disease, but might also 
entail social isolation and changes in health-related behaviour (alcohol and tobacco use), 
which might have an effect on the aggravation of symptoms (4, 5). 
There has been an increasing interest in sick-leave research in recent years. Nevertheless, 
most of the research has mainly focused on risk factors for sickness absence, rather than on 
outcomes of being sickness absent (3). The following prospective cohorts are examples of 
projects from which data have been used in order to investigate outcomes of being sickness 
absent: the national gas and electricity companies (GAZEL) study in France (6), the Whitehall 
II study in the United Kingdom (7), the 10-Town study in Finland (8) as examples of 
occupational cohort studies; the Danish Register-based Evaluation of Marginalisation 
(DREAM) study in Denmark (9) and the Insurance Medicine All Sweden (IMAS) study in 
Sweden (10) as examples of population-based register studies. The mentioned occupational 
cohort studies are based on specific occupational groups, such as municipal workers (8, 11, 12), 
employees in the private/public sector (9, 13), gas/electricity workers (6, 14-18), and civil 
servants (7, 19). While these studies have considerable strengths through comprehensive 
information from questionnaires, the study populations are selected, which might restrict 
generalisability of findings to the general population. Sick-leave data can also be retrieved 
from registers of employers and of private and public insurance companies. Such register data 
often enable longitudinal study designs. To date, however, population-based register data are 
only available in few countries (20). Information on sickness absence can also be acquired by 
self-reported data, but shortcomings of such data include recall bias (20, 21).  
Sickness absence can be measured in different ways (22-24). The number of measures used in 
the literature is extensive with more than 40 different measures (20, 22-24). This hampers 
comparison between different studies. The measures are usually constructed through three 
different units: sick-leave spell, time and person (20). Each of these units captures different 
aspects of sickness absence as a phenomenon. Based on these units, basic measures of 
sickness absence which are suitable for use in epidemiological studies have been previously 
suggested (24). Examples of these measures comprise length and duration (time based), 
frequency (spell based) and cumulative incidence (person based). The choice of sick-leave 
measures is related to the research question at hand and different measures may result in 
varying results. In order to give a more comprehensive view on the health conditions 
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investigated in epidemiological studies, the authors recommend combinations of measures 
related to spells, persons and time (24). As an example, sex differences were observed when 
using an incidence measure of psychiatric sickness absence, but not when using a time based 
measure (25). For these reasons, several different sick-leave measures related to the mentioned 
units have also been used in this thesis (see Methods).  
Research on sickness absence can be categorised according to what is studied, study design, 
studied population, type of data and analyses, scientific discipline, perspective taken with 
regard to the research questions, structural level of factors included in the analyses, and type 
of diagnoses included (26). Table 1 shows the categorisations of studies in the current thesis, 
which are marked in bold.  
Table 1. Categorisations of the performed studies in this thesis according to a structure for 
categorisations of studies on sickness absence and disability pension (26). Those relevant for 
the thesis are marked in bold. 
What is studied  -Design 
-Studied 
-Data 
-Analyses 
Scientific 
discipline  
Perspective 
taken in 
research 
questions  
Structural 
level of factors 
included in the 
analyses  
Diagnoses  
1. Factors that 
hinder or promote 
sickness 
absence/disability 
pension 
3. Factors that hinder 
or promote return to 
work 
2. “Consequences” of 
(being on) sickness 
absence/disability 
pension 
4. Sickness 
certification practice 
5. Methods, theories  
Study design 
-Cross sectional 
-Longitudinal 
-RCT, CT, etc. 
Studied 
General 
population 
Insured 
In paid work 
(general or 
special) 
Diagnosed 
Sickness absent 
Other 
Type of data 
Interview 
Questionnaire 
Register 
Medical files 
Insurance files 
Notes 
Documents 
Video 
Other 
Type of analyses 
-Qualitative 
-Quantitative 
Economy 
Law 
Management 
Medicine 
Psychology 
Sociology  
Public health 
Epidemiology 
Philosophy 
Other  
 
That of the: 
 
-Society 
-Insurance 
-Healthcare 
-Employer 
-Family 
-Patient 
-National 
-Local 
-Worksite 
-Health care 
-Family 
-Individual 
All together 
 
Mental 
Musculoskeletal 
Cancer 
Circulatory 
Infections 
 
Other  
 
1.1 Sickness absence 
1.1.1 The Swedish sickness insurance system 
The Swedish sickness insurance system regarding sickness absence covers all people above 
the age of 16, living in Sweden and having at least a minimum annual income from work, 
unemployment benefit, or parental benefit (2). The purpose of the sickness insurance system is 
to provide financial security in case of reduced work capacity due to a disease or injury. The 
compensation from the employer is referred to as sick pay, whereas compensation from 
Social Insurance Agency (SIA) is referred to as sickness benefit. According to the degree of 
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reduced work capacity, sickness benefit can be one-quarter, one-half, three-quarters, or full-
term of ordinary working hours.  
Sickness benefit amounts up to 80% of lost income. Employees receive sick pay from day 2-
14 of a sick-leave spell from the employer (the first day being a qualifying day) (2). From day 
15 employees can receive sickness benefit from SIA. A certificate from a physician is 
required from the eighth day of a sick-leave spell. Unemployed individuals and individuals 
on parental leave can be granted sickness benefit from SIA from the second day of a sick-
leave spell whereas self-employed individuals receive sick pay from SIA according to which 
insurance coverage they have chosen.  
Disability pension can be granted to all individuals aged 19-64 and living in Sweden whose 
work capacity has been reduced long term or permanently due to a disease or injury (2). Since 
2008, temporary disability pension can only be granted to young adults aged 19 to 29 years.  
In the last decade several interventions have been introduced to ensure higher quality in 
handling of sickness certification cases. One of these, introduced in 2007 general as well as 
diagnosis-specific recommendations regarding sickness certification (27-29). Previously, there 
was no official time limitation for how long a person could be on sickness absence with 
benefits. In 2008, the Swedish government launched new rules for sickness absence with the 
attempt to guarantee a low and stable level of sickness absence, to promote return to work 
earlier in the sick-leave spell, as well as to develop a standardised application of sickness 
insurance across the country (2, 30). Since July 2008, stricter assessments related to eligibility 
for sickness absence and disability pension were introduced and provision of sickness benefit 
for most absentees was limited to one year (2). Seriously ill people could receive sickness 
benefit for up to 914 days (2). In the same year, a rehabilitation chain was introduced which 
regulates how the reduction of work capacity should be assessed at different time points (2). 
Recent studies suggest that these new regulations had an impact on termination of sickness 
benefit and restricted transition to disability pension (27, 29, 31). 
1.1.2 Prevalence of sickness absence 
In most countries, sick-leave rates are rather stable over time, however, sick-leave rates have 
varied in some countries (1). For example, Norway had high sick-leave rates during the 
1990s- and 2000s and reached a peak in 2009 (32). Denmark, on the other hand, had fairly low 
sick-leave rates which showed an increasing trend during the beginning of the 2000s. In 
Finland, relatively stable sick-leave rates were observed compared to other Nordic countries. 
There were fluctuations in the number of sick-leave days per sick-leave insured person in 
Sweden, in both women and men from 1955 to 2013 (Figure 1) (33).  
Also, sex differences were observed. Since the 1980s, women have had higher number of 
sick-leave days than men in Sweden (Figure 1). Moreover, an increase in mental sickness 
absence has been observed in recent years (34). To date, mental and musculoskeletal 
diagnoses are the predominant sick-leave diagnoses (35, 36). The most frequent mental sick-
leave diagnoses are depression, anxiety, and stress-related disorders (36).  
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Figure 1. Number of sick-leave days with benefits from national Social Insurance Agency 
per sick-leave insured person, from 1955 to 2013 in Sweden (33). 
 
1.1.3 Factors associated with sickness absence 
1.1.3.1 Socio-demographic and socio-economic factors 
A number of previous studies have reported associations between several socio-demographic 
and socio-economic factors with sickness absence (2, 35-47). In Sweden, sickness absence due 
to mental diagnoses is more common among women than men (2). With regard to specific 
mental sick-leave diagnoses, alcohol-related diagnoses have been shown to be relatively more 
common among men, while stress-related and anxiety diagnoses are relatively more common 
among women (36). The sex difference with regard to sickness absence due to 
musculoskeletal diagnoses is less pronounced. Concerning sickness absence due to 
musculoskeletal diagnoses, the most common diagnostic group is back pain, which accounted 
for nine percent of the sick-leave spells in 2009 among men in Sweden (women eight 
percent) (35). Potential sex differences may be explained by differences in morbidity, 
occupation, and working conditions (37-39). 
Sickness absence has also been reported to be more common among older age groups (37, 40), 
individuals with lower educational level (40, 41), with economic difficulties (42), and with 
unemployment (40). Moreover, a higher prevalence of sickness absence was found in rural 
areas (2).  
A number of studies have reported associations regarding marital status as well as having 
children and subsequent sickness absence (43-45, 47). Higher risk of sickness absence was 
found among unmarried, divorced/separated, and widows/widowers than among married 
people (43). Some studies reported an association between female sex and having children and 
risk of sickness absence (44, 47). Here, having children has been discussed as representing a 
double workload, which might have an impact on sickness absence (47). However, results are 
conflicting and other studies have shown that having multiple roles, in terms of work career 
and children is positive for health and work capacity (45). Additionally, migrant status appears 
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to be associated with a higher risk of sickness absence (46). In this thesis, a number of socio-
demographic factors have been used as either exposure factors or covariates. These factors 
include sex, age, family situation, educational level, type of region of residence, and country 
of birth. 
1.1.3.2 Health-related factors 
Both mental and somatic complaints have been reported to predict sickness absence (48-59). 
Previous studies have shown associations of depressive and anxiety disorders (48-50), burnout 
(49, 51), and mental fatigue (49, 52) with subsequent sickness absence. Poor mental health might 
here be related to a job selection with poor working conditions or individuals with mental 
disorders might be more susceptible to psychosocial work stressors (53). Here also the 
possibility of reverse causality should be mentioned. This means that it is also likely that poor 
psychosocial working conditions are related to future mental health complaints (53).  
Not only mental disorders, but also somatic symptoms such as sleep disturbance (54), physical 
fatigue (52, 54, 55), musculoskeletal diseases (56), and being overweight (57) have been reported 
to predict sickness absence. Moreover, a number of studies have shown that adverse health 
behaviour can be associated with future sickness absence. Focus in those studies was 
particularly on the association of smoking (58) and of high alcohol consumption (58, 59) with 
high levels of sickness absence. In this thesis, health-related factors have been primarily 
conceptualised as consumption of specialised health care and being prescribed specific 
psychiatric medication, i.e., representing a measure of the severity of the underlying disease.  
1.1.3.3 Work-related factors 
Work can play an important role for individuals’ mental health. Besides providing a source of 
income, work can contribute to the structure of day and night, social contacts and a sense of 
meaning (60, 61). On the other hand, an adverse physical and/or psychosocial work 
environment can have a negative impact on mental well-being (37, 53, 61). For example, 
receiving social support from supervisors and colleagues has been demonstrated to be a 
protective factor for mental disorders such as depressive disorders (53). On the contrary, being 
exposed to poor working conditions or bullying are examples of risk factors for sickness 
absence (62-64). A number of studies have used the job demand-control-support model which 
was developed to measure the psychosocial working environment (65). Previous studies using 
this model showed that having high job demands in combination with low levels of control 
and support was associated with higher risk of sickness absence due to mental disorders (64, 
66) and of sickness absence in general (63). 
1.2 Mental disorders 
Understanding the concept of mental health plays an important role for forming a 
comprehensive understanding of mental disorders. To date, different definitions of the 
concept of mental health have been put forward (67, 68). According to the definition of the 
World Health Organization’s (WHO), mental health is “a state of well-being in which the 
individual realises his or her own abilities, can cope with the normal stresses of life, can work 
productively and fruitfully, and is able to make a contribution to his or her community” (68). 
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As health in general, mental health is influenced by multiple and interacting biological, 
psychological, social and environmental factors (68).  
On the other hand, mental disorders have been defined by the WHO as abnormal phenomena 
which are characterised by alterations in thinking, mood, or behaviour with personal distress 
and/or impaired functioning (67). Obviously, the concepts of mental health and mental 
disorders are not dichotomous concepts, and human behaviour lies on a continuum between 
mental health and mental disorders.  
There are two diagnostic systems for the classification of mental disorders. One is the 
Diagnostic and Statistical Manual of Mental Disorders with the currently available fifth 
edition (DSM-V) published by the American Psychiatric Association (APA) (69). Another 
commonly used manual produced by the WHO is the International Classification of Diseases 
(ICD-10), which presents a complete list of classification of mental and behavioural disorders 
(70). Diagnostic information in this thesis is based on the ICD-10 codes as they build the basis 
for reporting diagnostic codes in the registers from the National Board of Health and Welfare 
and the Swedish Social Insurance Agency. 
Depressive, anxiety, and stress-related disorders are often summarised as “common mental 
disorders” (CMD) (71). CMDs have a considerable impact on individuals’ lives through their 
effect on social and occupational functioning (72). Symptoms of these disorders include 
insomnia, fatigue, troubles in concentrating, forgetfulness, irritability, and somatic complaints 
(70, 73). It is common to have two or more mental disorders that occur together, which is 
known as comorbidity (67). Depressive disorders have, e.g., often been found to be comorbid 
with anxiety (74). Somatic diseases such as musculoskeletal disorders and cancer also 
commonly coexist with mental disorders (75-77).   
Onset, prevalence, and course of mental disorders are influenced by a multiplicity of factors. 
Possible factors include social and economic factors, demographic factors such as sex and 
age, and the presence of somatic diseases (67). Anxiety and depressive disorders appear to be 
more common among women, while substance use disorders and antisocial personality 
disorders are reported to be more common among men (67). Some studies also suggest that the 
prescription of psychotropic medicines, including antidepressants and anxiolytics is higher 
among women (78). Age is another important indicator of mental disorders. Compared to 
many somatic disorders, mental disorders are often characterised by an early age of onset (79), 
which might differ between types of mental disorders (79, 80). In addition, people who are 
socially isolated and people who are socio-economically disadvantaged have been shown to 
have poorer mental health than others (67). 
1.3 Suicide attempt and suicide 
Suicide, an intentional self-harm resulting in death, represents a considerable public health 
problem since it is an important cause of mortality worldwide (81). Worldwide, up to one 
million individuals are estimated to commit suicide annually (82). However, suicide rates vary 
considerably between regions and countries. In the European region, the highest suicide rates 
for both males and females are found in Eastern European countries, for instance, Lithuania, 
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Russian Federation, and Belarus (81-83). In Sweden, the suicide rate reached a peak in the 
beginning of the eighties and then declined (Figure 2) (84). The decline was prominent in 
individuals over 24 years, whilst individuals between 15-24 years showed stable trends of 
suicide during the last two decades (Figure 2) (84). In 2014, the suicide rate in Sweden was 
11.1 (per 100 000 inhabitants) in total, 6.1 for women and 16.2 for men (84). This was close to 
the average rate in the European region (82).  
 
Figure 2. Suicide rate per 100 000 inhabitants in different age groups in Sweden, 1980-2014 
(84). 
Non-fatal intentional self-harm occurs approximately 20 times more frequently than 
completed suicide and is the most significant risk factor for suicide in the general population 
(85). Many different terms, including parasuicide, suicide attempt and deliberate self-harm 
have been used to describe this behaviour (85). Deliberate self-harm has been defined as an 
intentional self-poisoning or self-injury, regardless of the underlying motivation and of any 
intent to die (85-87). The term parasuicide has been described as consisting of both suicide 
attempts and other self-harm behaviour (85, 88). Suicide attempt has been defined as a 
behaviour that is self-inflicted and potentially injurious with a nonfatal outcome and that 
there is evidence (either explicit or implicit) showing an intent to die (85). Considering that the 
intent of non-fatal intentional self-harm is difficult to assess, the WHO/EURO multicenter 
study on suicidal behaviour has been adopting the term “suicide attempt” also in the absence 
of a clear suicidal intent (88). In this thesis, the term suicide attempt has been used throughout 
in relation to the definition by the WHO/EURO multicentre study.  
Suicide attempt is often impulsive and up to one-third of the individuals surviving an attempt 
report not having had any suicidal intention (89). Age standardised rates of suicide attempt in 
the WHO/EURO study including 13 countries showed large international differences with 
low rates in southern European countries and high rates in northern Europe (88). In Sweden, 
the rate of inpatient care due to suicide attempt showed a dramatic increase among 
individuals aged 15-24 years during 1997 and 2007 and the rate declined after that, but 
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remained at a higher level than in the 1990s (90). With regard to individuals older than 24 
years, relative stable trends were seen over time (See Figure 3).  
 
Figure 3. Suicide attempt rate per 100 000 inhabitants in inpatient care for different age 
groups in Sweden, 1987-2013 (90). 
 
The choice of a specific method is an important factor in determining whether the outcome is 
fatal or not. Men in general tend to use more violent methods as hanging or shooting, while 
women more often use less violent methods as self-poisoning (83). The most common suicide 
method worldwide is poisoning, mainly through pesticide ingestion, especially in rural areas 
of many developing countries (83). In the USA, firearms are commonly used suicide methods 
due to their availability (83). In Sweden, poisoning is the main method of suicide among 
women, whereas hanging is the most commonly used method among men (84) The second 
most common methods for suicide in women and men are hanging and poisoning, 
respectively.  
Suicidal behaviour (i.e., suicide attempt and suicide) as a sensitive issue is often under-
reported (83). A large proportion of individuals who attempted suicide do not present to health 
care services (85). Previous studies showed that only approximately 25% of suicide attempters 
receive treatment in inpatient care (91). Even in countries with good register-based data, 
suicidal behaviour may be misclassified as an accident or recorded as another cause of death 
(81). In Sweden, the Forensic Department is responsible for conducting a forensic examination 
of the deceased - often with an autopsy - when the police suspects an unnatural death (84). The 
Forensic Department has autopsied approximately 97 percent of all suicides since 1990s. The 
cause of death which is reported on a death certificate is submitted to the National Board of 
Health and Welfare. Then, all diagnoses and injuries reported on the certificate are translated 
into ICD-codes. Since the introduction of the 8th revision of ICD in 1969 it is possible to 
classify death as an undetermined intent (84). A number of previous studies have included 
undetermined intent in order to limit under-reporting of suicide attempt or suicide and to 
account for temporal and geographical differences in ascertainment methods (92-94). This 
approach has also been used in this thesis.  
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1.3.1 Risk factors for suicide attempt and suicide 
People who commit suicide have to a large extent previously attempted suicide (83). Likewise, 
among people who attempted suicide, a substantial share will eventually commit suicide (95). 
Risk factors for suicide attempt and suicide overlap to some extent (83, 85). However, some 
differences have also been reported. The age of first onset of suicide attempt is often during 
adolescence and young adulthood (96). Older people have lower risk of suicide attempt, but 
when they attempt suicide they might be at higher risk to commit suicide subsequently (97). 
Suicide, on the other hand, is more common among older people (83). While being male is a 
risk factor for suicide, suicide attempt occurs more often among women (83, 85). A substantial 
body of evidence suggests that the risk of suicidal behaviour is high in divorced, unemployed, 
and lower educated people and in those with low income (98-101). Moreover, studies have 
shown that up to 90% of people who present to hospitals because of suicide attempt or those 
who commit suicide fulfil the criteria of  having at least one mental disorder (98, 102). Here, 
depressive disorders are the most common ones, followed by substance abuse and anxiety 
disorders (98, 102, 103). Individuals with severe mental disorders such as bipolar disorders, 
schizophrenia or personality disorders are also reported to have a high risk of suicide (104). 
Moreover, comorbidity is common (103, 105). 
Individuals with depressive disorders have a many times higher risk of attempting suicide or 
dying due to suicide than the general population (106, 107). The life time risk of suicide for 
individuals who meet the criteria for a depressive disorder is around 4-15% (108-110). 
Individuals with depressive disorders may sometimes commit suicide during the first 
depressive episode, which is likely related to alcohol misuse and impulsive-aggressive 
personality traits (110, 111). As mentioned earlier, a history of suicide attempt has been shown 
to be the strongest risk factor for suicide (105, 112). Up to 40% of suicide victims have 
previously attempted and those with a history of suicide attempt have an up to 40 times 
higher suicide risk than that of the general population (83, 113). Suicide risk after suicide 
attempt is particularly higher among men (114), older individuals (114), individuals with 
repeated suicide attempts (115), those who attempt suicide with strong suicidal intent (116), 
individuals with alcohol abuse (117), and those living alone (117). Suicide attempt and suicide 
are also associated with somatic disorders, including cancer (118, 119), epilepsy (119, 120), 
diabetes (121), HIV/AIDS (118, 119, 122), Huntington’s disease (118, 119), multiple sclerosis (118, 
119) and injury (118, 119, 123). Undetected mental disorders are likely to be co-occurring with 
these somatic disorders (119, 124).  
Moreover, results from previous studies show associations of suicidal behaviour and family 
history of suicide behaviour (125, 126), adverse childhood environment and experiences (93, 127), 
alcohol abuse (128), drug use (129), social isolation (130) and adverse life events (131). The above 
mentioned risk factors are often interlinked (85).  
1.4 Potential outcomes of being sickness absent 
Sickness absence can have an effect on the sick-listed individuals, their families, but also on 
employers, colleagues, social insurance systems and the society (3). In this thesis, some 
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possible outcomes for the individual being on sickness absence have been studied. Potential 
outcomes of being sickness absent can involve different types of consequences on well-being, 
working life, economy, social life and lifestyles etc. (3). Potential positive and negative 
outcomes of being sickness absent regarding different dimensions are described below (Table 
2) (3).  
Table 2. Summary of potential outcomes of being sickness absent regarding different aspects 
(3). 
Health  Health, e.g., in terms of well-being, ability to take action, sense of meaning, or quality of 
life may improve or become worse following a sick-leave spell.  
Work capacity Work capacity may improve or decline as an outcome of sickness absence. 
Disease  The disease causing sickness absence may improve or become worse during the sick-leave 
spell.  
Other diseases may develop during the sickness absence, e.g., depression. 
Sickness absence Sickness absence may lead to prolonged or future sickness absence. 
Disability 
pension  
Sickness absence may lead to disability pension. 
Premature death Sickness absence may increase the risk for premature death.  
Working life Sickness absence may be a risk for full or partial unemployment.  
Work conditions and work tasks can be changed in positive or negative ways. 
Career opportunities and personal finances may be influenced. 
Social life Social contacts and activities may be influenced in positive or negative ways. 
Life style  Exercise, diet, tobacco use, alcohol use, drug use, and risk behaviours (e.g., suicide attempt) 
may be changed in positive or negative ways. 
Emotional 
aspects 
Life satisfaction, self-confidence, self-image, and self-awareness may be altered in positive 
or negative ways.  
Stress and boredom may appear due to sickness absence. 
 
In order to review studies on potential outcomes of being sickness absent, a literature search 
via PubMed was conducted in May 2015 for studies published in scientific journals during 
2000 to 2015. The following search terms were used: sickness absence, sick leave, health 
outcome, social outcome, disability pension, mortality, suicide attempt, suicide, or recurrence 
based on the search terms used in a systematic review published in 2004 (3). The predominant 
number of the identified studies regarding subsequent outcomes of being sickness absent has 
focused on either disability pension or mortality as possible outcomes. Some other studies 
focused on subsequent health conditions, future sickness absence, work capacity, and life 
situation. 
1.4.1 Sickness absence and subsequent disability pension 
Several prospective cohort studies have reported a positive association between all-cause or 
diagnosis-specific sickness absence and subsequent disability pension (8, 9, 17, 132-147). The 
main findings from these studies were that long-term or increasing duration of sickness 
absence were associated with higher risks for being granted disability pension compared to 
those not being sickness absent (8, 17, 135, 146). Sickness absence with the following sick-leave 
diagnoses have been investigated: mental (17, 132, 137-140), musculoskeletal (17, 134, 138), 
circulatory (17, 132), nervous (132), respiratory (17, 132), and otoaudiological diagnoses (141). 
Also, two studies reported an association between partial sickness absence and subsequent 
partial disability pension (142, 143).  
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1.4.2 Sickness absence and mortality 
Associations between sickness absence and mortality have been studied in several European 
countries (Table 3). Among these studies, all-cause sickness absence, several sick-leave 
spells, and long sick-leave duration have been shown to be associated with higher risks of all-
cause mortality (7, 11, 13, 19, 148-150). Moreover, sickness absence has also been reported to be 
predictive of mortality due to cardiovascular diseases, cancer, and suicide (7, 11, 151, 152). 
Several studies have investigated specific sick-leave diagnoses and mortality, showing that 
sickness absence due to mental, musculoskeletal, circulatory, cancer, respiratory, digestive, 
and neurological diagnoses was associated with higher risk of subsequent premature death (6, 
7, 10, 15, 148, 152, 153).  
To date, a limited number of studies have reported association between sickness absence and 
suicide (10, 11, 15, 125, 149, 152-155). All-cause sickness absence has been found to be a risk 
indicator of suicide in a large prospective cohort study in Finland (11). Two Danish studies 
reported a similar association (125, 154). Moreover, in an occupational cohort study of 
employees of the French Gas and Electricity Company (GAZEL), mental sickness absence 
was a strong risk indicator of suicide (15). Also, a number of Swedish cohort studies reported 
a higher risk of suicide among people with increasing number of sick-leave days, sickness 
absence due to specific mental diagnoses, and due to musculoskeletal diagnoses (10, 149, 152, 
153, 155). Table 3 provides more detailed information on study design of the studies on 
sickness absence and subsequent mortality. 
1.4.3 Sickness absence and other outcomes 
Some previous studies have also focused on the association of sickness absence with 
outcomes such as sub-optimal health and mental disorders, measured in different ways (Table 
4). In a prospective study of the French GAZEL cohort, sickness absence was reported to be 
associated with subsequent depression (14). Compared with employees with no sickness 
absence during the study period, those with sickness absence were more likely to be 
depressed, after adjustment for socio-demographic and health-related factors. Both mental 
and somatic sickness absence were risk indicators of future depression.  
Moreover, sickness absence has been reported to be a risk indicator of future sub-optimal 
health (16, 18, 156, 157). Long-term sickness absence as well as sickness absence due to specific 
mental and somatic diagnoses were associated with subsequent sub-optimal health (16). 
Another prospective occupational cohort study showed similar associations, which differed 
by occupational positions (18). In addition, sickness absence has been observed to be a risk 
indicator of future sickness absence (12, 52, 158-160) (Table 4). Sickness absence has also been 
related to a number of subsequent adverse social situations: job termination and 
unemployment (161, 162), worse financial situation (163), or social exclusion (5)
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Table 3. Summary of studies on sickness absence and subsequent mortality (studies with suicide as outcome are indicated in bold). 
Author, year published, 
country 
Study design;  
Type of data 
Study 
period   
Exposure   Outcome 
measures  
No. in study 
population  
Covariates  Results 
Qin et al. 2000 (154), 
Denmark 
Prospective  
population based case-
control study; 
Register 
1980-1994 Sickness absence 
>3 weeks 
Suicide  811 suicide cases, 
79 871 controls 
Socio-demographic and 
socio-economic factors, 
disability pension, mental 
disorders, and drug use 
Sickness absence is associated 
with suicide in men.  
Qin et al. 2003 (125), 
Denmark 
Retrospective  
population based case 
control study; 
Register 
1981-1997 Sickness absence 
>3 weeks 
Suicide  21 169 suicide cases, 
423 128 controls  
Socio-demographic and 
socio-economic factors, 
disability pension, and 
mental disorders 
Sickness absence is associated 
with suicide in both men and 
women. 
Kivimäki et al. 2003 (19), 
UK 
Prospective 
occupational cohort 
study;  
Register, company 
records, survey 
1985-1998 Sickness absence 
< and >7 days 
All-cause 
mortality 
10 308 civil servants Age, employment grade, 
common clinical conditions, 
self-rated health, and chronic 
illness  
More sick-leave spells are 
associated with all-cause 
mortality. Sickness absence <7 
days seems to be protective. 
Vahtera et al. 2004 (11), 
Finland 
Prospective 
occupational cohort 
study;  
Register, company 
records 
1990-2001 Sickness absence 
< and >3 days 
All-cause and 
cause-specific 
mortality 
41 736 full time 
municipal 
employees 
Age, employment grade, and 
type of employment 
More than one spell is associated 
with all-cause and cause-specific 
mortality (Suicide, circulatory, 
cancer, alcohol related). 
Gjesdal et al. 2008 (148), 
Norway 
Prospective 
population-based 
cohort study;  
Register 
1994-2003 Sickness absence 
>8 weeks, 
diagnosis-specific 
sickness absence 
All-cause 
mortality 
3386 persons with 
sickness absence 
compared to 
256 654 inhabitants 
Age, income  All cause and cause-specific 
sickness absence are associated 
with all-cause mortality. 
Head et al. 2008 (7), UK   Prospective 
occupational cohort 
study;  
Register,  company 
records, survey 
1985-2004 Sickness absence 
>7 days, 
diagnosis-specific 
sickness absence 
All cause and 
cause-specific 
mortality 
6478 civil servants Age, sex, and employment 
grade  
Information on diagnoses of 
sickness absence improves 
prediction of mortality. 
Kivimäki et al. 2008 
(151), France 
Prospective 
occupational cohort 
study;  
Company records, 
survey  
1990-1992 Sickness absence 
>28 days 
All cause 
mortality 
17 948 employees in 
GAZEL  
Age, sex, socio-economic 
status, and comorbidity  
High number of sick-leave days 
and spells is associated with 
mortality. 
Singh-Manoux et al. 2008 
(150), UK and France 
Prospective 
occupational cohort 
study; 
Register, company 
records, survey  
1985-2004 
1989-2005 
Sickness absence 
≥15 days 
All cause 
morbidity and 
mortality 
10 308 civil servants 
in Whitehall II, 
20 625 employees in 
GAZEL 
Age, employment grade, and 
marital status 
Sickness absence is associated 
with mortality among men in the 
Whitehall II cohort.  
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Table 3. (Continued) 
Author, year published, 
country 
Study design;  
Type of data 
Study 
period   
Exposure   Outcome 
measures  
No. in study 
population  
Covariates  Results 
Ferrie et al. 2009 (6), 
France 
Prospective 
occupational cohort 
study;  
Company records 
1990-2007 Sickness 
absence >7 days, 
diagnosis-
specific sickness 
absence 
All-cause 
mortality 
19 235 employees in 
GAZEL 
 
Age, employment 
grade 
All-cause and diagnosis-specific 
sickness absence are associated with 
all-cause mortality. 
Lund et al. 2009 (13), 
Denmark 
Prospective 
population-based 
cohort study;  
Register 
2001-2004 Sickness 
absence 1-53 
weeks 
Al-cause 
mortality 
236 107 employees 
in private sector  
Age, sex, and 
employment grade 
Mortality increases with increasing 
duration in sickness absence. There 
are differences in sex and 
occupational grade. 
Melchior et al 2010 (15), 
France 
Prospective 
occupational cohort 
study;  
Register, company 
records 
1990-2008 Sickness 
absence >7 days, 
diagnosis-
specific sickness 
absence 
Cause-specific 
mortality 
19 962 employees in 
GAZEL 
Age, sex, 
employment grade, 
marital status, 
smoking, and 
alcohol use 
Sickness absence due to mental 
diagnoses is associated with suicide. 
Jansson et al. 2012 (152), 
Sweden 
Prospective 
population-based 
cohort study;  
Register 
2005-2009 Sickness 
absence due to 
musculoskeletal 
diagnoses 
All-cause and 
cause-specific 
mortality 
4 760 987 
individuals 
Socio-
demographics, in- 
and specialised 
outpatient care 
Sickness absence due to 
musculoskeletal diagnoses is 
associated with all-cause mortality 
and mortality due to cancer, 
circulatory diseases, mental 
disorders, and suicide. 
Mittendorfer-Rutz et al. 
2012 (10), Sweden 
Prospective 
population-based 
cohort study;  
Register 
2004-2008 Sickness 
absence due to 
mental 
diagnoses 
All-cause and 
cause-specific 
mortality 
4 857 943 
individuals 
Socio-
demographics, in- 
and specialised 
outpatient care 
Mental sickness absence is 
associated with all-cause mortality 
and mortality due to suicide, cancer, 
and circulatory diseases. 
Bryngelson et al. 2013 
(153), Sweden 
Prospective 
occupational cohort 
study;  
Register 
1990-2007 Sickness 
absence >90 
days due to 
mental 
diagnoses 
All-cause and 
cause-specific 
mortality 
244 990 employees 
within municipalities 
and counties in 1990 
and 764 137 in 2000 
Socio-
demographics, 
inpatient care 
Long-term mental sickness absence 
is associated with all-cause mortality 
and mortality due to suicide. 
Lemogne et al. 2013 
(155), France 
Prospective 
occupational cohort 
study; 
Register, company 
records, 
survey 
1989-2010 Sickness 
absence due to 
mental 
diagnoses 
Cause specific 
mortality 
20 625 employees in 
GAZEL. 
Age, sex, 
employment grade, 
alcohol use, 
smoking, height, and 
weight 
Mental sickness absence is 
associated with cardiovascular 
mortality and non-cardiovascular 
mortality. 
Björkenstam et al. 2014 (1
49), Sweden 
Prospective 
population-based 
cohort study;  
Register 
1994-2006 All-cause 
sickness 
absence, sick-
leave days 
All-cause and 
cause-specific 
mortality 
4 669 235 
individuals 
Socio-demographics 
and inpatient care 
Higher number of sick-leave days is 
associated with all-cause mortality 
and mortality due to circulatory 
disease, cancer, and suicide.  
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Table 4. Summary of studies on sickness absence and subsequent sub-optimal health, future sickness absence and adverse mental health 
outcomes  
Author, year published, 
country 
Study design;  
Type of data 
Study period   Exposure   Outcome 
measures  
No. in study 
population  
Covariates  Results 
Kivimäki et al. 2008 (157). 
UK 
Prospective 
occupational 
cohort study; 
Company records, 
survey 
1985-1993 Sickness 
absence >7 days 
Health status 5210 civil 
servants 
Age, sex, 
baseline health measures, 
employment grade, health- 
related risk factors, and 
psychosocial factors 
Low sick-leave rates are 
associated with positive 
change in health status among 
employees with poor health.  
Melchior et al. 2009 (14), 
France 
Prospective 
occupational 
cohort study; 
Company records, 
survey 
1996-1999 Sickness 
absence >7 days, 
diagnosis- 
specific sickness 
absence 
Depression  7391 employees 
in GAZEL 
Age, sex, marital 
status, employment grade, 
smoking, alcohol use, 
depressive symptoms, and 
work stress 
Mental and non-mental 
sickness absence predicts 
future depression. 
Roelen et al. 2010 (159), 
Netherlands 
Prospective 
occupational 
cohort study; 
Company records 
2001-2007 Diagnosis-
specific sickness 
absence 
Incidence of 
recurrent 
sickness absence 
after return to 
work 
137 172 
employees in 
Dutch Post and 
Telecom 
Sex, age, salary scales, 
socio-economic status, 
marital status, and type of 
employment 
Sickness absence due to 
musculoskeletal diagnoses 
has highest recurrence, 
followed by mental 
diagnoses. 
Vahtera et al. 2010 (16), 
France 
Prospective 
occupational 
cohort study; 
Company records, 
survey 
1990-2006 Sick-leave days 
and diagnosis-
specific sickness 
absence 
Self-rated health 15 320 
employees in 
GAZEL 
Sex, age, employment grade. 
and the year of retirement 
Employees with 30 absence 
days have higher risk for 
suboptimal health. Sick-leave 
diagnoses are associated with 
sustained suboptimal health. 
Ferrie et al. 2011 (18), 
France 
Prospective 
occupational 
cohort study; 
Company records, 
survey 
1990-2006 Sick-leave days 
and diagnosis-
specific sickness 
absence 
Sub-optimal 
health 
15 320 
employees in 
GAZEL 
Sex, age, and chronic illness Sickness absence of more 
than 30 days is associated 
with future sub-optimal health 
in all occupational positions. 
Gustafsson et al. 2011 
(156), Sweden 
Prospective cohort 
study; 
Register, survey 
2004-2006 Sickness 
presence and 
sickness absence 
Health problems 
and work 
capacity 
2181 employees Sex, age, education, socio-
economic status, work-
related factors 
Sickness presence and 
sickness absence are 
predictors of future poor 
health, physical complaints, 
low mental well-being and 
low work capacity. 
Koopmans et al. 2011 (158), 
Netherlands 
Prospective 
occupational 
cohort study; 
Company records 
2001-2007 Sickness 
absence due to 
common mental 
disorders 
(CMDs) 
Recurrent 
sickness absence 
after return to 
work 
9904 employees  
in Dutch Post 
and Telecom 
Sex, age, marital 
status, duration of 
employment, type of 
employment, and company 
Employees with a previous 
episode of sickness absence 
with CMDs are at higher risk 
of recurrent sickness absence 
with CMDs. 
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Table 4. (Continued) 
Author, year published, 
country 
Study design;  
Type of data 
Study period   Exposure   Outcome 
measures  
No. in study 
population  
Covariates  Results 
Roelen et al. 2011 (160), 
Netherlands 
Prospective 
occupational 
cohort study; 
Company records 
2004-2008 Sick-leave 
spells and 
durations 
Future sickness 
absence 
551 employees 
in a hospital 
Age and sex Sick-leave days and episodes 
are associated with risk of 
future sickness absence. 
Laaksonen et al. 2013 (12), 
Finland 
Prospective 
occupational 
cohort study; 
Company records, 
survey 
2000-2007 Sick-leave 
spells and 
durations 
Future sickness 
absence 
6934 municipal 
employees 
Employment grade, 
working conditions and 
health-related behaviours 
Preceding sickness absence is 
associated with risk of new 
sick-leave episodes. The 
association is stronger for 
longer sick-leave spells and 
for men. 
Roelen et al. 2013 (52), 
Norway 
Prospective 
occupational 
cohort study; 
Survey 
2008-2010 Sick-leave 
durations 
Future sickness 
absence 
2059 nurses Individual, 
private life, and work 
variables 
Number of sick-leave days 
predicts future sickness 
absence. 
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2 Aim 
2.1 General aims 
The general objective of this thesis was to investigate different aspects of the association 
between sickness absence and subsequent morbidity, suicide attempt and suicide, when 
simultaneously taking socio-demographics, previous and current morbidity and medication 
into consideration. 
2.2 Specific aims 
2.2.1 Study I 
The aim of the first study was to investigate all-cause and diagnosis-specific sickness absence 
as well as sick-leave duration as risk indicators for suicide attempt and suicide among women 
and men. 
2.2.2 Study II 
The second study aimed to examine whether sickness absence measured in different ways 
(regarding length, grade (full- or part- time), diagnoses, and number of spells), socio-
demographics, medication, and health care predict suicide attempt and suicide among patients 
with depressive disorders from in- or specialised outpatient health care. 
2.2.3 Study III 
The aim of the third study was to identify trajectories of sickness absence and disability 
pension prior to suicide and to describe associations of socio-demographic and health care 
factors with such trajectories. 
2.2.4 Study IV 
The aim of the fourth study was to 1) scrutinise the association between all-cause and 
diagnosis-specific sickness absence and sick-leave duration with subsequent risk of inpatient 
care due to mental and somatic disorders, as well as suicide attempt and suicide, and 2) 
analyse possible differences in socio-demographics and previous and current morbidity-
related measures in individuals on sickness absence before and after the changes in the social 
insurance regulations in 2008 in Sweden. 
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3 Methods 
The design and methods applied in each study are summarised in Table 5.  
3.1 Design and study population 
Population-based prospective/retrospective cohort design was applied in the four studies in 
the thesis. 
In Study I, 4 923 404 individuals who lived in Sweden on 31 December 2004, aged 16-64 
years, without old-age or disability pension during 2005 and with no ongoing sick-leave spell 
at the turn of 2004/2005 were included. Individuals with old-age or disability pension were 
considered not to be under risk of being sickness absent and therefore they were not included. 
By excluding sick-leave spells at the turn of 2004/2005, an investigation of incident sickness 
absence was enabled. The final cohort was followed up from 1 January 2005 for six years 
through 31 December 2010, with respect to suicide attempt and suicide.   
In Study II, the study population comprised all individuals, aged 16-64 years and living in 
Sweden on 31 December 2004, not on old-age or disability pension throughout 2005, who 
had in- or specialised outpatient health care due to depressive disorders in 2005. In- or 
specialised outpatient health care due to depressive disorders was defined according to the 
ICD-10 codes F32 (depressive episode) or F33 (recurrent depressive disorder). Among 
individuals hereby identified, those who between 2000 and 2005 also had had an in- or 
specialised outpatient care due to schizophrenia (ICD-10 code F20-29) or bipolar disorder 
(F31), were excluded. Thus, 21 096 individuals were included in the study and they were 
followed up from 1 January 2006 through 31 December 2010, with respect to suicide attempt 
and suicide. 
In Study III, the study population included all individuals who committed suicide during 
2007-2010 when aged 22-65 years (n=4209). Suicide was defined according to the ICD-10 
codes X60-X84 and Y10-Y34 (event of undetermined intent), as suicide is often under-
reported or recorded as undetermined intent (92-94). An annual time-scale was applied where 
time point T-5 represented 5 years prior to suicide (i.e. 2002-2005). The time during T-5 to T-
1 (i.e., 2002-2009) was used to investigate how trajectories of sickness absence and disability 
pension developed over the five years prior to suicide. 
In Study IV, there were 4 477 678 individuals alive, resident in Sweden, aged between 20 and 
64 years on 31 December 2005 included at baseline. An additional cohort comprised 
individuals alive, resident in Sweden, aged between 20 and 64 years on 31 December 2008 
(n=4 500 400) at baseline. Individuals with old-age or disability pension during 2006/2009 in 
the respective cohort as well as individuals with ongoing sick-leave spell at the turn of 
2005/2006 and 2008/2009 in the respective cohort were excluded. The two cohorts were 
followed up for two years (2007-2008 and 2010-2011, respectively) with respect to inpatient 
care and suicidal behaviour. 
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Table 5. Overview of the four studies.  
 Study I Study II Study III Study IV 
Aim To examine associations 
between sickness absence 
in general, different 
diagnoses of sickness 
absence, sick-leave 
duration with subsequent 
suicide attempt and 
suicide 
To examine whether 
measures of sickness 
absence in different 
ways, socio-
demographics, 
medication, and health 
care were associated with 
subsequent suicide 
attempt and suicide 
among patients with 
depressive disorders 
To identify trajectories 
of sickness absence and 
disability pension five 
years before suicide and 
to describe associations 
of socio-demographic 
and health care factors 
with sickness absence 
and disability pension 
trajectories 
To investigate cohort 
differences and 
associations between all-
cause, diagnosis-specific 
sickness absence and 
sick-leave duration with 
subsequent inpatient 
health care and suicidal 
behaviour before and 
after the social insurance 
regulatory change  in 
2008 
Design Prospective cohort study 
with baseline data on 31 
December 2004 and 
follow-up until 31 
December 2010 
Prospective cohort study 
with baseline data on 31 
December 2004 and 
follow-up until 31 
December 2010 
Retrospective cohort 
study with baseline data 
regarding inclusion in 
2007-2010. 
Retrospective data from 
2002-2005  
Prospective cohort study 
with baseline data on 31 
December 2005 (Cohort 
2006) and 31 December 
2008 (Cohort 2009), and 
follow-up until 31 
December 2008 (Cohort 
2006) and until 31 
December 2011 (Cohort 
2009) 
Study population; 
n 
4 923 404 (47.5% 
women; aged 16-64 at 
baseline) 
21 096 (59.9% women; 
aged 16-64 at baseline) 
4209 (29.1% women; 
aged 17-61 at baseline) 
4 477 678 (Cohort 2006, 
47.4% women) and 
4 500 400 (Cohort 
2009,47.7% women) 
both aged 20-64 at 
baseline 
Inclusion criteria On 31 December 2004: 
alive, living in Sweden, 
aged 16-64, not on old 
age pension or disability 
pension during 2005, not 
on ongoing sick-leave 
spell at the turn of 
2004/2005 
On 31 December 2004: 
alive, living in Sweden, 
aged 16-64, not on old-
age pension or disability 
pension during 2005, had 
in- or specialised 
outpatient health care due 
to depressive disorders in 
2005 
In 2007-2010: had 
committed suicide when 
aged 22-65 
On 31 December 2005 or 
31 December 2008: alive, 
living in Sweden, aged 
20-64, not on old age 
pension or disability 
pension during 
2006/2009, not on 
ongoing sick-leave spell 
at the turn of 2005/2006 
and 2008/2009, 
respectively 
Data sources LISA1, MiDAS2, 
National Patient Register, 
Prescribed Drug 
Register, Cause of Death 
Register 
LISA1, MiDAS2, 
National Patient Register, 
Prescribed Drug 
Register, Cause of Death 
Register 
LISA1, National Patient 
Register, Cause of 
Death Register 
LISA1, MiDAS2, 
National Patient Register, 
Prescribed Drug 
Register, Cause of Death 
Register 
Outcome measures  Suicide attempt 
(n=17  693) and suicide 
(n=3356) 
Suicide attempt 
(n=1 209) and suicide 
(n=152) 
Trajectories of sickness 
absence and disability 
pension months 
Mental inpatient care 
(Cohort 2006: n=30 986; 
Cohort 2009: n=34 843), 
somatic inpatient care 
(Cohort 2006: 
n=536 404; Cohort 2009: 
n=559 090), suicide 
attempt (Cohort 2006: 
n=3350; Cohort 2009: 
n=3579) and suicide 
(Cohort 2006: n=1821; 
Cohort 2009: n=1232). 
Factors included in 
the analyses 
Sex, age, educational 
level, type of region of 
residence, country of 
birth, family situation, 
previous suicide attempt, 
previous in- and 
specialised outpatient 
mental health care and  
current antidepressants 
Sex, age, educational 
level, type of region of 
residence, country of 
birth, family situation, 
previous suicide attempt, 
previous and ongoing 
inpatient mental and 
somatic health care and 
current antidepressants 
and anxiolytics 
Sex, age, educational 
level, type of region of 
residence, country of 
birth, family situation, 
suicide attempt, in- and 
specialised outpatient 
mental and somatic 
health care 
Sex, age, education, type 
of region of residence, 
country of birth, family 
situation, previous 
suicide attempt, previous 
and ongoing in- and 
specialised outpatient 
mental and somatic 
health care and current 
antidepressants 
Statistical analyses Descriptive 
Cox proportional hazards 
regression models 
Descriptive 
Cox proportional hazards 
regression models 
Descriptive 
Group-based trajectory 
modelling 
Multinomial logistic 
regression 
Chi2-test 
Descriptive 
Cox proportional hazards 
regression models 
1LISA:  Longitudinal Integration Database for Health Insurance and Labour Market Studies; 
2MiDAS:  Micro Data for Analysis of the Social Insurance. 
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3.2 Data sources 
The studies in the thesis were based on the Insurance Medicine All Sweden (IMAS) project 
(10), including de-identified annual register data obtained from nationwide registers from 
Statistics Sweden (SCB), the National Board of Health and Welfare, and the Social Insurance 
Agency (SIA). The personal identity numbers (PIN) attributed to all Swedish inhabitants 
were used to link information from the different registers (164).  
3.2.1 Longitudinal Integration Database for Health Insurance and Labour 
Market Studies (LISA) 
The Longitudinal Integration Database for Health Insurance and Labour Market Studies 
(LISA) was established in 1990 and is updated annually by SCB (165). LISA includes all 
individuals aged 16 years and older who were registered as living in Sweden on 31 December 
for the here studied years (165). The database contains information on social-demographics 
and social insurance measures (165). LISA data was used in Study I, II, and IV to define the 
respective study population. LISA was also used in all the four studies to obtain information 
on socio-demographic factors at baseline, including sex, age, educational level, country of 
birth, type of region of residence, and family situation. In Study III, information on sickness 
absence and disability pension during 2002-2009 was obtained from LISA. In Study I, II, and 
IV information on emigration from LISA was used for censoring in the calculation of the 
follow-up time.  
3.2.2 Micro Data for Analysis of the Social Insurance (MiDAS) 
The database called Micro Data for Analysis of the Social Insurance (MiDAS) includes 
annual data from SIA, from the year 1994 and onwards, covering detailed information on 
sickness benefits and disability pension (166). In Study I, II, and IV, MiDAS data on sickness 
absence regarding start date, sick-leave diagnoses and duration/length, number of sick-leave 
spells and sick-leave grade (i.e. full- or part-time) have been used. The register includes 
information on the main sick-leave diagnoses since 2005, using ICD-10 codes. Moreover, 
information on disability pension during exposure time was used to exclude individuals from 
the study population in Study I, II, and IV.  
3.2.3 The National Patient Register  
The National Patient Register from the National Board of Health and Welfare includes 
information on inpatient care and specialised outpatient care and was established in 1964, 
when data on inpatient care due to somatic disorders was started to be collected in six 
Swedish counties (167). In 1973, register data on mental inpatient care was started to be 
collected. Since 2001, it is compulsory  to report specialised outpatient visits (167). Coverage 
of the inpatient care register is almost 100% (167). The National Patient Register does not 
include information from primary health care. In all four studies, the National Patient 
Register was used to obtain data on mental and somatic in- and specialised outpatient care, 
and suicide attempt from inpatient care. In Study II, information on depressive disorders from 
in- and specialised outpatient care was obtained from the National Patient Register to identify 
the study population.  
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3.2.4 The Prescribed Drug Register 
The Prescribed Drug Register, held by the National Board of Health and Welfare, was 
established in July, 2005 (168). The register includes information with personal identity 
number (PIN) for all dispensed prescribed drugs in Sweden (168). The database contains 
information on patients and prescribed drugs (e.g., dispensed item, dosage, amount, and date) 
(168). All drugs are categorised according to the Anatomical Therapeutic Chemical (ATC) 
classiﬁcation system (169). Information on antidepressants and anxiolytics from the Prescribed 
Drug Register was used in Study I, II, and IV.  
3.2.5 The Cause of Death Register 
The Cause of Death Register is held by the National Board of Health and Welfare. The 
register was established in 1952, aiming to record all deceased individuals, regardless of 
whether the death occurred in Sweden or abroad (84). The causes of death are for the years 
studied classified according to ICD-10 (84). In Study I, II, and IV, the Cause of Death Register 
was used to identify the outcome, suicide deaths. In Study III, the register was used to 
identify the study population (completed suicide). The register was also applied to exclude 
individuals who died during the exposure time in Study II and IV. In Study I, II, and IV, 
information on death was also used for censoring in the calculation of the person time. 
3.3 Exposure, covariates and outcome measures 
The exposure, covariates, and outcome measures included in the four studies are described 
below. All socio-demographic, health care and medication factors in Study I, II, and IV were 
measured either before exposure, before and during the years of exposure, or during the years 
of exposure. In Study III, these factors were measured at a time point five years before 
suicide (T-5).   
3.3.1 Sickness absence and disability pension 
In Study I, II, and IV, sickness absence was used as the exposure and measured in different 
ways, considering the number of spells, the extent (grade), the time (duration and length), as 
well as diagnoses.   
3.3.1.1 Spells 
With regard to information on spells, the focus in Study I, II, and IV was on: a) first new 
(incident) sick-leave spell initiated in 2005 (Study I), 2006 (Study IV), and 2009 (Study IV); 
b) all new (incident) sick-leave spells initiated in 2005 (Study II), and c) ongoing (prevalent) 
sick-leave spells in 2005 (baseline) and the year before baseline (Study II). In Study II, the 
number of all new sick-leave spells initiated during 2005 was measured and grouped as 1 or 
more than 1 spells. Individuals with no incident or prevalent sick-leave spell during the 
respective exposure year were used as the reference group in Study I, II, and IV. 
3.3.1.2 Grade 
Moreover, sick-leave grade was considered in Study II and measured by full-time and part-
time sickness absence and classified as either having full-time sickness absence throughout in 
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all new sick-leave spells during 2005, or as having at least some part-time (<100%) sickness 
absence in any new sick-leave spell during 2005.  
3.3.1.3 Duration and length 
With regard to the time on sickness absence, both duration of the first incident sick-leave 
spell and length when combining sick-leave days from several spells, were used. Sick-leave 
duration comprises the number of sick-leave days in the first new spell initiated during the 
year of exposure, while sick-leave length was defined as the sum of sick-leave days in all new 
spells initiated during the exposure period (24). In Study I and IV, sick-leave duration was 
defined as the number of gross days and grouped into five categories: 1-14, 15-90, 91-180, 
181-365, and more than 365 days. That is, the sick-leave spell was followed until the end, 
even if that extended into subsequent years. In Study II, sick-leave length, namely the total 
number of gross days was measured and categorised in 1-90, 91-365, and more than 365 
days. Here, fewer categories of sick-leave length were used due to the fewer cases of suicidal 
behaviour.  
3.3.1.4 Diagnoses 
With regard to diagnoses of sick-leave spells, both all-cause and diagnosis-specific sickness 
absence were used (Study I, II, and IV). Diagnoses of sickness absence were classified 
according to ICD-10. In Study I, sick-leave diagnoses of the first new sick-leave spell in 2005 
were categorised into 20 groups: as mental and behavioural disorders (F00-F99), and specific 
somatic diagnoses, i.e. all remaining 19 chapters of the ICD-10. Sick-leave diagnoses which 
were associated with less than 20 cases of suicide attempt/suicide and those with missing 
diagnoses (20%) were combined into other disorders in the analyses.  
In Study II, the sick-leave diagnoses of the new sick-leave spells initiated during 2005 were 
categorised as at least one new sick-leave spell with a mental diagnosis (F00–F99), as having 
somatic sick-leave diagnoses (all other ICD-10 codes), or as missing information on 
diagnoses (1.6%). In Study IV, sick-leave diagnoses of the first new sick-leave spell in 
2006/2009 were classified into: common mental disorders (CMD) which included 
“depressive disorders” (F32-F33), “anxiety disorders” (F40-42), and “stress-related 
disorders” (F43); all other mental diagnoses (F00-F31, F34-F39, F44-F99); musculoskeletal 
diagnoses (M00-99) and other somatic (other than musculoskeletal) diagnoses. Missing 
diagnoses (≈13%) were categorised as an own group.  
3.3.1.5 Sickness absence/disability pension 
In Study III, a combined measure of days with sickness absence and disability pension was 
used as a measure of work incapacity. Prevalent sickness absence and disability pension days 
during a year were combined and calculated as the mean annual number of sickness absence 
and disability pension net days from the time period five years before the suicide (T-5) to the 
time period of one year prior to suicide (T-1; i.e. 2006-2009) in order to measure work 
incapacity. The number of net days was thereafter transformed to the number of annual 
months with sickness absence and disability pension. 
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3.3.2 Socio-demographic factors 
Socio-demographic factors at baseline were used either as covariates (Study I, II, and IV) or 
as exposure factors (Study II and III). These factors included information on sex, age, 
educational level, type of region of residence, country of birth, and family situation. 
Information on labour market status was included in Study II. In Study I, all analyses were 
stratified by sex.  
In Study II, sub-groups of classification of socio-demographic factors which were 
hypothesised to be associated with lower risks compared to other groups in relation to 
suicidal behaviour were used as reference groups. In Study I and II, age was classified as 16-
24 (reference group in Study I), 25-34, 35-44 (reference group in Study II), 45-54, 55-64 
years. In Study III, age groups were divided into 17-27 (reference group), 28-38, 39-49, 50-
61 years. In Study IV, age was classified as 20-24 (reference group), 25-34, 35-44, 45-54, 55-
64 years. Educational level was grouped as compulsory (≤9 years), high school (10-12 years) 
and university (>12 years) (reference group in Study I-IV) in all the studies. Labour market 
status was classified into two groups in Study II: employed/self-employed (reference group) 
and unemployed. Type of region of residence was measured according to the number of 
inhabitants in a specified area (170) and categorised as big cities (reference group in all the 
studies), medium sized cities, and small towns/villages in all the studies.  
In Study I, III, and IV, country of birth was categorised into Sweden (reference group in all 
the studies), other Nordic countries, EU 25 without Nordic countries, and the rest of the 
world. In Study II, the categories “other Nordic countries” and “EU 25” were combined due 
to fewer cases of outcome. The variable family situation was based on two variables in the 
LISA dataset: family position and family type. In Study I, III, and IV, family situation was 
classified into married/living with partner without children (reference group in all the 
studies), married/living with partner with children, single/divorced/separated/widowed 
without children, single/divorced/separated/ widowed with children, and adolescents living 
with parents, 16-20 years. In Study II, the category “adolescents living with parents” was 
combined with single living without children due to few outcome cases. 
3.3.3 Health care factors and medication 
Information on in- and specialised outpatient care due to mental and somatic disorders was 
used as covariates (Study I, II, and IV), exposure measures (Study II and III) or outcome 
measures (Study IV). As a covariate and exposure variable, previous and/or ongoing in- and 
specialised outpatient care due to mental (ICD-10:F00-F99) or somatic (other ICD-10 codes) 
disorders was categorised based on the median length of inpatient care and median number of 
outpatient care visits during a defined period of time. When health care was treated as an 
outcome, presence or absence of such care was dichotomised.  
Information on antidepressant and/or anxiolytic prescription was used as covariates (Study I, 
II, and IV) or exposure (Study II). It was coded following the ATC codes, namely N06A and 
N05B. Information on antidepressant and anxiolytic prescription was used as a proxy of 
medical severity of underlying mental disorders. In Study I and IV, antidepressants were 
  23 
included in the analyses as a dichotomised variable. In Study II, antidepressants and 
anxiolytics were categorised as no antidepressants and anxiolytics, only antidepressants, only 
anxiolytics and both antidepressants and anxiolytics. 
3.3.4 Suicidal behaviour  
In this thesis, suicide attempt was not only used as a measure of exposure/covariate (Study I-
IV), but also an outcome measure (Study I, II, and IV). Suicide attempt was measured 
according to ICD-10 codes X60-X84 (intentional self-harm) in Study I and II, while an 
approach of combining ICD-10 codes X60-X84 and Y10-Y34 (event of undetermined intent) 
was used in Study III and IV(92-94). Combination of these codes intends to compensate for 
under-reporting of suicidal behaviour as well as geographical and temporal differences in 
ascertainment methods. Sensitivity analyses of excluding cases with undetermined intent 
were performed and similar results were observed. Suicide attempt was dichotomised as 
suicide attempt and no suicide attempt in all the studies. 
Death due to suicide was an outcome measure in Study I, II, and IV in this thesis. In Study III 
suicide was used to define the study population. Suicide was measured according to ICD-10 
X60-X84 in Study I and II. ICD-10 codes X60-X84 and Y10-Y34 were combined for suicide 
in Study III and IV. Sensitivity analyses of excluding cases with undetermined intent were 
performed and similar results were observed.  
3.4 Statistical analyses 
Descriptive statistics were performed in all the studies, including calculating frequencies and 
percentages, means with standard deviations, and medians. In Study I-III, proportions of the 
exposure measures, covariates and outcome measures were presented separately for women 
and men. Chi2-tests were used to test possible sex differences in Study II and III and cohort 
differences in Study IV. 
Cox proportional hazards regression models were applied in Study I, II and IV to analyse the 
association between sickness absence and inpatient care due to mental and somatic disorders 
(Study IV), suicide attempt (Study I, II, and IV), and suicide (Study I, II, and IV) with crude 
and adjusted hazard ratios (HR) and 95% confidence intervals (CI). These models were 
applied after testing that the proportional hazard assumption was met. In Study I, the analyses 
were stratified by sex when the partial likelihood ratio test indicated an interaction with sex. 
In Study IV, the partial likelihood ratio test was performed in order to test an interaction 
between measures of sickness absence and the two cohorts in relation to the different 
outcome measures.  
Individuals were followed until the event (inpatient care due to mental or somatic disorders, 
suicide attempt, death due to suicide), death (due to other reasons than suicide), emigration, 
or end of follow-up whichever came first in Study I, II, and IV. In Study I, follow-up time 
started from the first day of the first new sick-leave spell with benefits in 2005. Individuals 
with no sickness absence were followed from 1 January 2005. In Study II and IV, follow-up 
time was started after the exposure year for all individuals. Besides the crude model, a 
number of covariates were also adjusted for. In Study I, socio-demographic factors were 
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adjusted for in the first model, while additional information on previous mental health care 
from inpatient and specialised outpatient care, suicide attempt from inpatient care and current 
antidepressant prescription were considered in the final model. Similar as in Study I, in Study 
IV social-demographic factors were adjusted for in the first model and then previous and 
ongoing mental and somatic disorders from in- and specialised outpatient care, previous 
suicide attempt from inpatient care and current antidepressant prescription were additionally 
adjusted for. In Study II, multivariate models included socio-demographic, health care, 
medication, and sickness absence factors which were significantly related to the outcome in 
the crude model. Due to the collinearity of different measures of sickness absence, only sick-
leave spells and sick-leave diagnoses were included in the multivariate models for suicide 
attempt and suicide, respectively (as these two sickness absence measures were strongest 
associated with the respective outcome). In addition, other sickness absence variables were 
separately taken into consideration in the models (excluding the previously mentioned ones) 
adjusting for socio-demographic factors, health care, medication, and suicide attempt. 
In Study III, group-based trajectory modelling was used to estimate trajectories of sickness 
absence and disability pension from the time span of 5 years (T-5) to the time span of one 
year (T-1) before suicide. This procedure is based on a mixture model that provides the 
capacity to identify subgroups of individuals who follow distinct trajectories during the time 
of observation and estimates a regression model for each discrete group (171). The Bayesian 
information criterion (BIC) was applied to test the best-fitted model related to the number of 
groups, i.e. determine the optimal number of trajectory groups. The BIC scores are negative 
values in which those closer to 0 indicate a better fit of the model.  
Multinomial logistic regression and chi2-tests were applied to estimate associations of socio-
demographic and health care characteristics in each trajectory group of sickness absence and 
disability pension in Study III. Individuals with missing values in the variables on 
“education”, “type of region of residence”, and “family situation” were excluded when 
performing the chi2-test and the multinomial logistic regression. The likelihood ratio chi2-test 
in the multinomial logistic regression was used to assess whether socio-demographic and 
health care factors were associated with type of trajectory in the full model. Moreover, the 
Nagelkerke R2 values were analysed to estimate the strength of the associations. By 
consecutively excluding each factor from the full model, differences in R2 for each factor 
were calculated in order to examine the contribution of a given factor to the full model.  
Statistical analyses were performed using statistical software SPSS for Windows V.20.0/22.0 
and/or SAS for Windows version 9.4 (SAS-based procedure “Traj” (171)).  
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4 Results 
The results of the four studies are presented below.  
4.1 Study I 
The cohort of Study I consisted of 4 923 404 individuals and there were 2 337 295 women 
(47.5%) and 2 586 109 men. Of the study population, 8.5% of the women and 5.2% of the 
men had at least one new sick-leave spell in 2005. In general, women had longer sick-leave 
spells than men. During the six years of follow-up, 0.4% of women and 0.3% of men 
attempted suicide, whilst 0.1% of men and 0.03% of women committed suicide. 
All-cause sickness absence was associated with a higher HR of suicide attempt after adjusting 
for socio-demographic factors, previous mental health care and suicide attempt, and 
antidepressants among both women (HR 2.37; 95% CI 2.25-2.50) and men (HR 2.69; 95% CI 
2.53-2.86).  
Table 6 shows that the crude HR of suicide attempt among women was highest for those on 
mental sickness absence (HR 6.16; 95% CI 5.76-6.59), followed by sickness absence due to 
symptoms and signs, diagnoses of the digestive system, injury/poisoning, and diagnoses of 
the musculoskeletal system (range of HRs: 1.28-1.94). Among men, the crude HR of suicide 
attempt was also highest for mental sickness absence (HR 11.99; 95% CI 11.03-13.03). The 
other diagnoses of sickness absence which were associated with higher HRs of suicide 
Table 6. Crude and adjusted hazard ratios and 95% confidence intervals (CI) for suicide 
attempt, following a sick-leave spell in 2005 due to different sick-leave diagnoses among 
women and men. 
Sick-leave, diagnostic 
categories  
Suicide 
attempts 
Model 0a Model 1b Model 2c 
 n (%) Hazard ratios (95% CI) 
Women     
Mental diagnoses  972 (2.2) 6.16 (5.76-6.59) 8.42 (7.86-9.02) 2.98 (2.77-3.21) 
Nervous diagnoses  21 (0.3) 0.95 (0.62-1.46) 1.54 (1.00-2.36) 1.31 (0.85-2.01) 
Respiratory diagnoses   51 (0.4) 1.10 (0.84-1.45) 1.90 (1.44-2.50) 1.57 (1.19-2.07) 
Digestive diagnoses   42 (0.7) 1.87 (1.38-2.54) 2.67 (1.97-3.61) 2.13 (1.57-2.89) 
Musculoskeletal diagnoses 217 (0.5) 1.28 (1.12-1.46) 1.87 (1.64-2.15) 1.64 (1.43-1.88) 
Symptoms and signsd 64 (0.7) 1.94 (1.52-2.49) 2.75 (2.15-3.52) 2.11 (1.65-2.70) 
Injury and poisoning 94 (0.6) 1.57 (1.28-1.92) 2.38 (1.94-2.92) 2.08 (1.70-2.56) 
No sickness absence  7890 (0.4) 1 1 1 
Men     
Mental diagnoses 611 (2.8) 11.99 (11.03-13.03) 12.92 (11.88-14.07) 3.64 (3.32-4.00) 
Nervous diagnoses   31 (1.0) 4.13 (2.90-5.87) 5.08 (3.57-7.23) 3.77 (2.65-5.37) 
Circulatory diagnoses   32 (0.4) 1.61 (1.14-2.28) 2.59 (1.82-3.67) 2.16 (1.52-3.06) 
Respiratory diagnoses   26 (0.3) 1.44 (0.98-2.12) 1.77 (1.20-2.60) 1.39 (0.94-2.04) 
Digestive diagnoses   30 (0.4) 1.63 (1.14-2.34) 1.96 (1.37-2.80) 1.81(1.26-2.59) 
Musculoskeletal diagnoses 153 (0.4) 1.72 (1.46-2.01) 1.94 (1.65-2.28) 1.79 (1.53-2.11) 
Injury and poisoning 151 (0.6) 2.51 (2.14-2.96) 2.39 (2.04-2.81) 2.13 (1.81-2.51) 
No sickness absence  6111 (0.3) 1 1 1 
a Model 0: Crude.  
b Model 1: Adjusted for age, educational level, type of region of residence , country of birth, and family situation.  
c Model 2: Adjusted for age, educational level,  type of region of residence , country of birth, family situation, previous in- and 
specialised outpatient care due to mental disorders, previous suicide attempt from inpatient care, and antidepressants in 2005. 
d Including abnormal clinical and laboratory findings. 
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attempt among men were for instance diagnoses of the nervous system, injury/poisoning as 
well as diagnoses of the musculoskeletal and the digestive system (range of HRs: 1.44-4.13).  
In the final models, the HRs were strongly reduced for mental sickness absence, somewhat 
stronger among men (Table 6). Still, significant results persisted among women (HR 2.98; 
95% CI 2.77-3.21) and men (HR 3.64; 95% CI 3.32-4.00). The other sick-leave diagnoses 
which showed higher HRs of suicide attempt among women and men in the multivariate 
models included injury and poisoning, digestive diagnoses, and musculoskeletal diagnoses 
(range of HRs: 1.64-2.13). Additionally, women on sickness absence due to respiratory 
diagnoses and symptoms and signs had higher HRs of suicide attempt, while sickness 
absence due to diagnoses of the nervous system and the circulatory system was predictive of 
suicide attempt among men. The partial likelihood ratio test showed a significant interaction 
of sex and sickness absence due to mental diagnoses and diagnoses of the nervous system 
with regard to subsequent suicide attempt (p<0.001). Sickness absence due to these diagnoses 
was associated with significantly higher HRs for subsequent suicide attempt in men than in 
women. 
Moreover, there was a higher HR of suicide attempt with increasing duration (sick-leave 
days) among women and men. The HR for suicide attempt was 3.35 among women with 
sickness absence longer than 365 days (95% CI 3.13-3.80) in the final model, while the HR 
of suicide attempt was 3.46 among men with sickness absence of 181-365 days (95% CI 
2.93-4.08) after controlling for all covariates. In general, men with different sick-leave 
durations with the exception of more than 365 days had higher HRs of suicide attempts than 
women (p<0.05). 
Also for suicide high HRs were found among women and men on all-cause sickness absence 
in the crude models (Table 7). In the final models, higher risks of suicide were found among 
women (HR 1.91; 95% CI 1.60-2.29) and men (HR 1.92; 95% CI 1.71-2.14) on sickness 
absence compared to those without sickness absence. Table 7 shows that women and men 
Table 7. Crude and adjusted hazard ratios and 95% confidence intervals (CI) for suicide, 
following a sick-leave spell in 2005 due to different sick-leave diagnoses among women 
and men. 
Sick-leave, diagnostic 
categories  
Suicide Model 0a Model 1b Model 2c 
n (%) Hazard ratios (95% CI) 
Women     
Mental diagnoses  79 (0.2) 6.69 (5.29-8.46) 6.69 (5.26-8.49) 2.74 (2.12-3.53) 
Musculoskeletal diagnoses  22 (0.05) 1.75 (1.14-2.68) 1.76 (1.15-2.70) 1.58 (1.03-2.43) 
No sickness absence  585 (0.03) 1 1 1 
Men     
Mental diagnoses  156 (0.7) 8.48 (7.20-9.97) 7.88 (6.69-9.28) 2.96 (2.48-3.54) 
Musculoskeletal diagnoses 63 (0.2) 1.99 (1.55-2.56) 1.78 (1.38-2.29) 1.66 (1.29-2.14) 
Injury and poisoning  46 (0.2) 2.15 (1.61-2.89) 1.91 (1.43-2.56) 1.76 (1.32-2.36) 
No sickness absence  2193 (0.1) 1 1 1 
a Model 0: Crude.  
b Model 1: Adjusted for age, educational level, type of region of residence , country of birth, and family situation.  
c Model 2: Adjusted for age, educational level, type of region of residence , country of birth, family situation, previous in- 
and  specialised outpatient care due to mental disorders, previous suicide attempt from inpatient care, and antidepressants 
in 2005. 
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with sickness absence due to mental diagnoses had particularly high HRs of suicide. This 
pattern remained even after controlling for all covariates (women: HR 2.74; 95% CI 2.12-
3.53; men: HR 2.96; 95% CI 2.48-3.54). Moreover, the risk estimates of suicide were 1.58 
and 1.66 for women and men on sickness absence due to musculoskeletal diagnoses in the 
multivariate model. The HR of suicide was 1.76 for men on sickness absence due to injury 
and poisoning. Also, different sick-leave durations were predictive of suicide among women 
and men. The HR of suicide was 3.55 among women and 2.34 among men with sickness 
absence of 181-365 days. 
4.2 Study II 
The cohort in study II consisted of 12 647 women (59.9%) and 8449 men, who were treated 
in in- or specialised outpatient health care due to depressive disorders in 2005. During the 
five years of follow up, 1209 individuals attempted suicide while 152 individuals committed 
suicide. Regarding sickness absence in 2005, 31.5% had new (incident) sick-leave spells. 
Considerable proportions of individuals had only one new sick-leave spell (25.3%), had full-
time sickness absence during all spells (16.8%), had more than 365 days of sickness absence 
of spells initiated in 2005 (11.6%), and new sick-leave spells due to mental diagnoses 
(25.0%). 
In this study, a number of sickness absence measures, socio-demographic factors, health care 
factors as well as different types of medication were investigated in relation to subsequent 
suicide attempt and suicide. In the univariate models, most of the analysed factors were 
associated with higher HRs for suicide attempt and suicide. After adjusting for socio-
demographics and health care factors, new sick-leave spells, full-time spells, spells exceeding 
365 days, having 1 or more sick-leave spells, and spells due to mental diagnoses were found 
to be associated with higher HRs of suicide attempt (range of HRs1.18-1.44) (Table 8).  
In addition, in the multivariate models a higher risk of subsequent suicide attempt was found 
to be higher among women than among men. In contrast, male sex was associated with a 
two-fold higher risk of suicide than female sex. Young age (16-24 years old) was associated 
with a higher risk of attempting suicide (HR1.47; 95% CI 1.21 to 1.78) compared with 
patients aged 35-44 years. Further, low and medium educational level, and living without a 
partner and without children were associated with higher HRs of suicide attempt. On the 
other hand, older age (45-64 years old), and living in small towns were observed to be 
associated with lower HRs of suicide attempt. Moreover, living with a partner and with 
children was associated with a lower HR of suicide. 
Dispensed prescription of both antidepressants and anxiolytics showed a two-fold higher HR 
of suicide attempt and suicide compared with patients with no prescription of antidepressants 
or anxiolytics. Patients who were only prescribed antidepressants had a HR of 1.34 for 
suicide attempt. Hospital stay due to mental disorders during 2000-2005 and previous suicide 
attempt during 2000-2004 compared with no hospital stay and no previous suicide attempt 
was associated with two to three-fold higher HRs of suicide attempt and suicide. Also, 
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associations between long inpatient care stays due to somatic disorders and subsequent 
suicide attempt were observed, which showed HRs of 1.79 and 1.81 for suicide attempt. 
4.3 Study III 
The study population of this study consisted of 4209 individuals who committed suicide in 
the years 2007 to 2010. Five groups of different trajectories of sickness absence and disability 
pension (SA/DP) months during the five years prior to suicide were identified as the best 
fitting model by using the BIC-based procedure in the trajectory analyses (Figure 4). The five 
groups were labelled as follows: “Constant Low”, “Constant High”, “Increasing Low”, 
“Increasing High”, and “Decreasing”. 
The “Constant Low” group consisted of a large proportion of individuals (46.4%) who 
committed suicide with constantly few months of SA/DP over the years prior to suicide. In 
total, 30.4% of individuals with high level of SA/DP belonged to the “Constant High” group. 
On average, they had more than 10 months of SA/DP annually. The “Increasing Low” and 
the “Increasing High” groups included 9.2% and 6.9% of the individuals with completed 
suicide, respectively. Both of the groups primarily had increasing SA/DP months during the 
time before suicide with different increasing patterns. The “Increasing Low” group started 
Table 8. Crude and adjusted hazard ratios and 95% confidence intervals (CI) for 
suicide attempt in individuals who in 2005 had in- or specialised outpatient care due 
to depressive disorders, following a sick-leave spell in 2005 measured in different 
ways.  
Sickness absence                           Model 0a Model 1b 
n (%)  Hazard ratios (95% CI) 
Sick-leave grade    
    No sick-leave spell 513 (5.6) 1 1 
    Full-timec  257 (7.2) 1.32 (1.14-1.54) 1.32 (1.12-1.56) 
    Part-time 174 (5.6) 1.01 (0.85-1.20) 1.11 (0.91-1.34) 
Length (days)d     
    No sick-leave spell 513 (5.6) 1 1 
    1-90  119 (5.8) 1.06 (0.87-1.29) 1.22 (0.99-1.51) 
    91-365  127 (5.9) 1.08 (0.89-1.31) 1.08 (0.88-1.32) 
    >365 185 (7.5) 1.37 (1.16-1.62) 1.39 (1.15-1.68) 
Number of spells     
    No sick-leave spell 513 (5.6) 1 1 
    1 spell 330 (6.2) 1.12 (0.98-1.29) 1.18 (1.01-1.39) 
    ≥2 spells 101 (7.7) 1.42 (1.15-1.76) 1.44 (1.15-1.81) 
Sick-leave diagnoses    
    No sick-leave spell 513 (5.6) 1 1 
    Spells with mental diagnosese 363 (6.9) 1.25 (1.09-1.43) 1.25 (1.08-1.46) 
    Spells with somatic diagnoses  50 (4.8) 0.88 (0.66-1.17) 1.13 (0.84-1.53) 
    Spells with missing diagnoses 18 (5.5) 1.02 (0.64-1.64) 1.13 (0.71-1.82) 
Sickness absence    
    No sick-leave spell 513 (5.6) 1 1 
    Ongoing sick-leave spellsf 265 (5.1) 0.91 (0.79-1.06) 1.03 (0.87-1.22) 
    New sick-leave spells 431 (6.5) 1.18 (1.04-1.34) 1.23 (1.06-1.43) 
a Model 0: Crude. 
b Model 1: Each sickness absence variable adjusted separately for socio-demographic, health care, and  medication 
factors. 
c Full-time: in all sick-leave spells during 2005. 
d Length (days): sum of total days in all sick-leave spells during 2005. 
e Spells with mental diagnoses: at least one new sick-leave spell in 2005 with a mental diagnosis. 
f Ongoing sick-leave spells: without any new sick-leave spell and ongoing from the years preceding 2005. 
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with having a few SA/DP months five years before the suicide (T-5). In this group, SA/DP 
months increased only marginally up until the time span of 2 years before suicide (T-2), when 
the increase became sharp. On the other hand, the “Increasing High” group had a strong 
increase of SA/DP months from five years prior to suicide and onwards and continued with 
the strong increase until T-2. The “Decreasing” group consisted of 7.1% of the individuals 
and showed a decrease in SA/DP over the study period (Figure 4).  
Figure 4. SA/DP trajectories during the five years (T-5 to T-1) prior to suicide, mean number 
of net SA/DP months per year.  
 
Further, associations of socio-demographic and health care characteristics with the different 
trajectory groups were explored. All socio-demographic and health care factors were 
significantly associated with the trajectory groups (P<0.05) with the exception of “country of 
birth” and “type of region of residence”. After controlling for all socio-demographic and 
health care factors in the full model, the significant results remained. Age had a more 
important role than other factors in the full model.  
Younger men and individuals with higher education, who were adolescents living with their 
parents, as well as those who had neither mental nor somatic inpatient care nor suicide 
attempt were overrepresented in the “Constant Low” group. Still, as much as 43.8% of the 
individuals in this group had had specialised outpatient somatic health care with 1-2 visits at 
baseline. On the other hand, the “Constant High” group predominantly comprised older 
women and individuals with lower education and those with more health care and suicide 
attempts. There was a larger proportion of individuals of female sex, middle age (39-49 
years), with high school education, and who were living alone with children included in the 
“Decreasing” group. With regard to health care characteristics, approximately 10-15% had 
attempted suicide or had mental or somatic in- or specialised outpatient care exceeding the 
median number of days or visits of the study population at baseline in the “Decreasing” 
group. The two groups with increasing SA/DP months showed somewhat different 
distributions of socio-demographic and health care characteristics. Compared to the 
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“Increasing High” group, individuals in the “Increasing Low” group tended to be younger, 
with higher education and with less somatic and mental health care. 
4.4 Study IV 
In this study the associations of sickness absence and subsequent morbidity and suicidal 
behaviour were investigated in two cohorts (one before and one after considerable changes 
in social insurance regulations in 2008). These cohorts (baseline in 2006 versus 2009) 
consisted of 4 477 678 and 4 500 400 individuals, respectively. During the two years of 
follow-up of the first cohort (2006), 30 986 individuals (0.7%) and 536 404 individuals 
(12.0%) were treated in inpatient health care due to mental and somatic disorders during 
2007-2008, respectively. Moreover, 3350 individuals (0.1%) were admitted to inpatient 
care due to suicide attempt and 1821 individuals (0.04%) committed suicide during 2007-
2008. In the latter cohort (2009), 34 843 individuals (0.8%) and 559 090 individuals (12.4%) 
had mental and somatic inpatient health care during follow-up, respectively. In total, 3579 
individuals (0.1%) attempted suicide and 1232 individuals (0.03%) died due to suicide 
during 2010-2011. Individuals with sickness absence in the two cohorts were significantly 
different with regard to all measured characteristics and outcome measures with exception 
of sex and subsequent suicide. 
 
All-cause and diagnosis-specific sickness absence as well as different sick-leave durations 
were associated with higher risks of mental inpatient health care compared to those without 
sickness absence in both cohorts in the univariate models (Table 9). The partial likelihood 
ratio test showed that individuals with sickness absence due to CMD and other mental 
diagnoses and sickness absence longer than 365 days in 2009 had higher HRs of subsequent 
Table 9. Crude and adjusted hazard ratios and 95% confidence intervals (CI) for mental 
inpatient health care, following the first new sick-leave spell due to mental diagnoses and 
long sick-leave duration, in 2006 and 2009, respectively. 
Sickness absence Inpatient 
mental care 
Model 0a Model 1b Model 2c 
 n (%) Hazard ratios (95% CI) 
 Sickness absence in 2006 
Sick-leave diagnoses     
    CMDd 2491 (3.8) 6.67 (6.40-6.95) 7.10 (6.81-7.40) 1.67 (1.59-1.74) 
    Other mental diagnoses 1074 (16.9) 32.05 (30.15-34.07) 27.11 (25.50-28.83) 2.39 (2.24-2.54) 
Sick-leave duration     
    >365 days 1450 (3.9) 6.82 (6.47-7.19) 7.29 (6.91-7.69) 1.86 (1.76-1.97) 
No sickness absence  23 782 (0.6) 1 1 1 
 Sickness absence in 2009 
Sick-leave diagnoses     
    CMDd 2326 (4.9) 7.34 (7.04-7.66) 7.83 (7.50-8.17) 1.64 (1.57-1.72) 
    Other mental diagnoses 984 (21.1) 35.56 (33.37-37.90) 29.39 (27.57-31.32) 2.33 (2.18-2.49) 
Sick-leave duration     
    >365 days 1025 (6.7) 10.39 (9.76-11.06) 10.57 (9.93-11.26) 2.02 (1.89-2.15) 
No sickness absence  28 434 (0.7) 1 1 1 
aModel 0: Crude. 
bModel 1: Adjusted for sex, age, educational level, type of region of residence , country of birth, and family situation. 
cModel 2: Adjusted for sex, age, educational level, type of region of residence , country of birth, family situation, 
previous and ongoing inpatient and specialised outpatient care due to mental and somatic disorders, previous suicide 
attempt from inpatient care, and antidepressants in 2006/2009. 
dCMD: Common mental disorders. 
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mental inpatient health care compared to those with such sickness absence in 2006 in the 
univariate models. After adjusting for socio-demographic factors, previous and ongoing 
health care factors, previous suicide attempt and antidepressant prescription, all sick-leave 
variables were still associated with higher HRs of subsequent mental inpatient care in both 
cohorts. The associations between sickness absence due to CMD and other mental 
diagnoses as well as sickness absence longer than 365 days with mental inpatient health 
care were attenuated more strongly among those on sickness absence in 2009 than those on 
sickness absence in 2006 after controlling for all covariates (Table 9). 
In the crude model for somatic inpatient care, all-cause sickness absence, sickness absence 
due to CMD, and musculoskeletal diagnoses and other somatic diagnoses and sickness 
absence more than 14 days in 2009 were found to be associated with significantly higher risk 
estimates than such sickness absence in 2006. All-cause sickness absence, sickness absence 
due to CMD and musculoskeletal diagnoses as well as sick-leave duration longer than 180 
days in 2009 remained to be associated with higher HRs of subsequent somatic inpatient 
health care compared to the HRs related to these sick-leave measures in 2006 after 
controlling for all covariates (Table 10).  
Higher HRs of suicide attempt and suicide were found in relation to all-cause sickness 
absence, specific sick-leave diagnoses and sick-leave duration in both cohorts in the crude 
analyses. Especially, sickness absence due to CMD and other mental diagnoses as well as 
sick-leave durations >90 days showed prominently high HRs of subsequent suicide attempt 
and suicide. The high risk estimates of suicide attempt remained in most of the sick-leave 
variables after adjustment for all covariates, with few exceptions. The HRs of subsequent 
Table 10. Crude and adjusted hazard ratios and 95% confidence intervals (CI) for somatic 
inpatient health care, following the first new sick-leave spell due to different diagnoses and 
long sick-leave duration, in 2006 and 2009, respectively. 
Sickness absence Somatic inpatient care  Model 0a Model 1b Model 2c 
 n (%) Hazard ratios  (95% CI) 
           Sickness absence in 2006 
Sick-leave diagnoses     
    CMDd 10 913 (16.8) 1.57 (1.54-1.60) 1.39 (1.36-1.42) 1.15 (1.13-1.17) 
    Musculoskeletal diagnoses 16 996 (18.8) 1.78 (1.75-1.81) 1.72 (1.69-1.75) 1.41 (1.38-1.43) 
Sick-leave duration     
    181-365 days 6538 (25.4) 2.57 (2.51-2.63) 2.41 (2.35-2.47) 1.79 (1.74-1.83) 
    >365 days 10 813 (29.0) 3.01 (2.95-3.07) 2.79 (2.73-2.84) 2.09 (2.05-2.13) 
No sickness absence  450 397 (11.1) 1 1 1 
 Sickness absence in 2009 
Sick-leave diagnoses     
    CMDd 8928 (18.7) 1.68 (1.65-1.72) 1.48 (1.45-1.51) 1.18 (1.16-1.21) 
    Musculoskeletal diagnoses 14 336 (21.1) 1.94 (1.90-1.97) 1.87 (1.84-1.91) 1.44 (1.41-1.46) 
Sick-leave duration     
    181-365 days 5680 (29.2) 2.91 (2.83-2.99) 2.74 (2.67-2.81) 1.86 (1.81-1.91) 
    >365 days 6015 (39.2) 4.29 (4.19-4.40) 3.97 (3.87-4.08) 2.59 (2.52-2.66) 
No sickness absence  484 682 (11.6) 1 1 1 
aModel 0: Crude. 
bModel 1: Adjusted for sex, age, educational level, type of region of residence , country of birth, and family situation. 
cModel 2: Adjusted for sex, age, educational level, type of region of residence , country of birth, family situation, previous 
and ongoing inpatient and specialised outpatient care due to mental and somatic disorders, previous suicide attempt from 
inpatient care, and antidepressants in 2006/2009. 
dCMD: Common mental disorders. 
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suicide attempt were notably higher for those with sickness absence of more than 365 days in 
2006 and 2009 (HR 2.14; 95% CI 1.84-2.50 vs. HR 1.82; 95% CI 1.46-2.27). For suicide, 
higher HRs were found related to sickness absence due to CMD in 2006 and 2009 and 
sickness absence due to other mental diagnoses in 2006 compared to those without sickness 
absence in the respective cohort. Sick-leave duration in 2006 was associated with higher risks 
of suicide except for sick-leave days longer than 365 days. Moreover, 15-365 days of 
sickness absence in 2009 was associated with higher HRs of suicide than those without 
sickness absence after controlling for all covariates.  
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5 Discussion 
5.1 Main findings 
The main findings in this thesis include that mental and specific somatic sickness absence as 
well as sick-leave duration were associated with higher risks of subsequent suicide attempt 
and suicide among both women and men compared to individuals without a new sick-leave 
spell. Analyses were adjusted for socio-demographic factors, health care, and medication. An 
association was also found between sickness absence, which was measured in different ways, 
and subsequent suicide attempt among patients with depressive disorders from in- or 
specialised outpatient care. Here, patients with depressive disorders on full-time sick-leave 
spells, spells exceeding one year, mental sickness absence, and those having one or more 
sick-leave spells had a higher risk of suicide attempt compared to those without sickness 
absence, after adjustment for all covariates. Associations between sickness absence and 
subsequent morbidity and suicidal behaviour were observed similarly before and after 
considerable changes of the social insurance regulations in Sweden in 2008. Still, sickness 
absence due to CMD and musculoskeletal diagnoses and sickness absence longer than 180 
days in 2009 were associated with higher HRs of subsequent somatic inpatient care than such 
sickness absence in 2006. Five different trajectory groups of SA/DP during the five years 
prior to suicide were identified. Almost half of those who committed suicide had constantly 
low levels of SA/DP during those five years, while 30% had constantly high levels of SA/DP 
before their suicide. The different trajectories were associated with different socio-
demographic profiles and health care factors five years before suicide. The distributions of 
these characteristics were particularly different in the group with constantly low as opposed 
to constantly high SA/DP levels. 
5.2 Discussion of results 
The main findings of this thesis are discussed below. 
5.2.1 Sick-leave diagnoses and subsequent morbidity/suicidal behaviour  
Mental disorders are common among individuals with suicidal behaviour. Studies in this 
thesis showed that sickness absence due to mental diagnoses, including CMD and other 
mental diagnoses was also a prominent risk marker for later suicide attempt and suicide not 
only in the general population but also in patients with depressive disorders from in- or 
specialised outpatient care. This association was also found with regard to sickness absence 
measured before and after the regulatory changes in Sweden in 2008. The findings are 
consistent with previous studies, reporting higher risk of suicidal behaviour among sickness 
absentees with mental diagnoses (15, 153, 155). The finding on sickness absence being a marker 
of subsequent suicidal behaviour also in depressed patients has not been reported before. It is 
of particular note that sickness absence which was measured in different ways was an equally 
strong risk factor for subsequent suicidal behaviour as a number of well-established risk 
markers in depressed patients, e.g., female sex for subsequent suicide attempt (85). 
In men, sickness absent due to mental diagnoses was found to be associated with a somewhat 
higher HR of subsequent suicide attempt compared to the risk estimate among women. Also, 
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the risk estimates of future suicide attempt were more strongly reduced among men with 
mental sickness absence after controlling for all covariates, than among women. This might 
suggest that men might have a higher severity of the underlying mental disorder when 
sickness certified with mental diagnoses. Sex differences in the prevalence and clinical 
manifestations of mental disorders, a higher threshold among men for reporting and seeking 
help due to mental complaints, and a gender bias in health care regarding identifying mental 
disorders, may partly explain the observed sex differences (172-174).  
Moreover, higher risks of suicide attempt and suicide among individuals with sickness 
absence due to a number of different somatic diagnoses were found compared to those 
without sickness absence (Study I). For example, findings showed higher HRs of suicide 
attempt and suicide among individuals with sickness absence due to musculoskeletal 
diagnoses. This finding corresponds with a previous study, which reported a higher risk of 
suicide related to sickness absence due to musculoskeletal diagnoses compared to those 
without sickness absence (152). In addition, many somatic disorders often occur with pain 
and/or psychosocial stress in case of fatal somatic disorders and limitations in social life, 
which may result in a higher risk of suicidal behaviour (119). Other potential explanations for 
the association of somatic sickness absence include a co-occurring or unrecognised mental 
disorder (175). Unmeasured residual confounding of an underlying mental disorder might be 
possible in this study. Information on mental disorders which were treated outside of 
specialised healthcare or not treated with antidepressants, as well as undetected and untreated 
mental disorders was not available. Thus, it is possible that unrecognised or unmeasured 
comorbid mental disorders underlie the association of somatic sickness absence and 
subsequent suicidal behaviour.   
Association between somatic sickness absence and later suicidal behaviour was also found to 
be sex specific in Study I. A two-fold risk of suicidal behaviour in men on sickness absence 
due to injury/poisoning was observed compared to men without sickness absence. This might 
be explained by underlying alcohol abuse or dependence being more frequent in men than in 
women and being related to both injuries and suicidal behaviour (176). Also, a higher risk of 
suicide attempt in women sickness absent due to symptoms and signs than women without 
sickness absence was found. This diagnostic group may include, for instance, chronic fatigue 
syndrome, which is more prevalent in women than in men, and probably associated with a 
considerable degree of depression as well as functional impairment and disability with regard 
to social, physical and occupational aspects (177). Moreover, men on sickness absence due to 
diagnoses of the nervous system had higher HRs of subsequent suicide attempt than women. 
Previous studies regarding this association have reported inconsistent findings (119). Future 
studies are needed to investigate potential sex differences in the association of sickness 
absence due to somatic diagnoses with subsequent suicidal behaviour. 
An association between diagnosis-specific sickness absence and inpatient care due to mental 
and somatic disorders was found (Study IV). This is in line with previous studies reporting 
higher risks of depression and sub-optimal health related to diagnosis-specific sickness 
absence compared to individuals not on sickness absence (14, 16). Additional findings from 
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Study IV suggest that sickness absence due to CMD in 2009 was associated with a higher HR 
of subsequent somatic inpatient care than sickness absence due to CMD in 2006. In this 
thesis, sickness absence has been measured before and after the considerable changes in the 
social insurance regulations in 2008. These findings might reflect that individuals on sickness 
absence due to CMD after the regulatory change were more likely to have a higher medical 
severity or any comorbid somatic disorders than those with such sickness absence before the 
new regulation was introduced.  
Moreover, the high HRs of inpatient care due to mental disorders among sickness absentees 
due to mental diagnoses in 2009 were more strongly reduced after additionally adjusting for 
health care factors and antidepressant prescription than among those on mental sickness 
absence in 2006 (Study IV). These findings suggest that individuals on sickness absence in 
2009 might also have had a higher severity of the underlying mental disorders compared to 
those with sickness absence in 2006. The descriptive statistics in Study IV showed that a 
larger proportion of individuals on sickness absence in 2009 had antidepressants prescription, 
longer inpatient care, more frequent outpatient care as well as previous suicide attempt than 
those on sickness absence in 2006. Still, reasons for a potentially higher medical severity in 
sickness absentees in 2009 compared to those in 2006 remain to be explained. A possible 
explanation includes the fact that the new regulations introduced in 2008 implied stricter rules 
for granting disability pension, which might have resulted in individuals with higher medical 
severity being sickness absent in 2009 than in 2006. 
5.2.2 Sick-leave measures and subsequent morbidity/suicidal behaviour  
Both the duration of the first new sick-leave spell in Study I and IV and sick-leave length of 
all sick-leave spells initiated during a year in Study II were found to be associated with higher 
HRs of suicide attempt and suicide. To our knowledge, this is the first study addressing sick-
leave duration and length as risk markers for subsequent suicide attempt, while such an 
association has been previously reported for suicide (11, 149, 153). In Study IV, the results 
showed that increasing duration of the first new sick-leave spell was associated with a higher 
risk of subsequent inpatient care compared to not having a new sick-leave spell. This finding 
is consistent with previous studies, reporting an association between long sick-leave duration 
and subsequent morbidity (16, 18).  
Higher HRs of hospitalisation due to somatic disorders among individuals with a long sick-
leave duration (>180 days) in 2009 than those sickness absent in 2006 were found. To the 
best of our knowledge, this is the first study to compare two cohorts before and after the new 
social insurance regulations introduced in Sweden with regard to subsequent health 
outcomes. Generally, the new rules implied that eligibility for sick-leave benefits was limited 
to one year (2). Still, individuals with serious disease and reduced work capacity can be 
granted sickness benefits for a longer time (2). Hence, individuals with sick-leave duration 
exceeding one year in 2009 may have a higher medical severity and/or work incapacity 
related to the sickness absence than those in 2006. This might have resulted in the higher risk 
estimates of subsequent morbidity related to sickness absence in 2009 than in 2006. 
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In Study II, sickness absence was also measured in different ways. A higher risk of 
attempting suicide was found among those with full-time sickness absence and among those 
with one or more sick-leave spells compared to those without sickness absence. One previous 
study showed associations between more than one sick-leave spell and subsequent suicide 
attempt in individuals with sickness absence due to stress-related mental disorders (178). More 
sick-leave spells, full-time sickness absence, as well as longer sick-leave duration/length 
might not only be indicators of the severity of the disease, but might also entail social 
isolation and changes in health behaviour (e.g., high alcohol and tobacco use, little physical 
exercise) (3, 4). This might have an effect on the aggravation of symptoms and increase 
suicidal behaviour (3, 4). Future research is required to scrutinise these different measures of 
sickness absence as risk indicators for suicide attempt and suicide by taking the severity of 
symptoms as well as eventual comorbidity into account. 
5.2.3 Trajectories of sickness absence and disability pension before suicide 
In Study III, five different trajectories of SA/DP in the five years prior to suicide were 
identified. This may reflect the general knowledge that suicide victims consist of a 
heterogeneous group with regard to etiology, health care seeking behaviour, the suicidal 
process, and underlying diseases (83). In this study, a large proportion (46.5%) of the 
individuals either showed stable high levels (30.4%) or increasing number (16.1%) of annual 
SA/DP months preceding suicide. Individuals with high/stable levels had a mean of 10 
SA/DP months annually. This is the first study, also internationally, investigating trajectories 
of SA/DP months prior to suicide. Recent studies focusing on such trajectories before first 
diagnosis of multiple sclerosis and of diabetes, respectively, found lower levels of work 
incapacity, i.e., SA/DP months compared to the findings related to individuals completing 
suicide (179, 180). A Swedish cohort of individuals with multiple sclerosis reported a 
proportion of around 23% with increasing and constant high levels of SA/DP months prior to 
first diagnosis (179). The mean of annual months related to the group with high levels of 
SA/DP was around 10 months. Another study which investigated two cohorts, i.e., a Finnish 
(<29%) and a French (<13%) occupational cohort reported much lower proportions of 
high/increasing work incapacity in individuals prior to first diagnosis of diabetes (180). Also 
lower levels of SA/DP prior to diabetes diagnoses were reported. High levels of SA/DP can 
here be regarded to be associated with the type and severity of the underlying diagnoses of 
SA/DP (50, 181). As discussed above, a large proportions of individuals with completed suicide 
suffer from mental disorders (83), and individuals with high and stable work incapacity before 
suicide might here reflect a group of patients with severe mental disorders.  
On the other hand, approximately half of the individuals with completed suicide (46.4%) had 
few SA/DP months before suicide. This compares to higher proportions of individuals with 
low levels of work incapacity prior to multiple sclerosis in a recent study based on a Sweden 
cohort (>50%), and prior to first diagnosis of diabetes in a study based on a Finnish (>70%) 
and a French (>80%) occupational cohort (179, 180). Obviously, trajectories of SA/DP prior to 
suicide and/or prior to the first diagnosis of specific chronic diseases can be assumed to 
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differ. More research on work incapacity trajectories prior and post non-fatal self-harm 
behaviour and specific mental disorders is warranted.  
5.2.4 Factors associated with sickness absence/disability pension and suicidal 
behaviour 
Results in Study III showed that several socio-demographic factors were associated with 
different trajectories of SA/DP. Age showed the strongest associations. This is in line with 
previous studies reporting that SA and DP rates increase with age (37). It is thus reasonable to 
find higher proportions of older individuals in the “Constant High” group with many months 
of SA/DP prior to suicide whereas higher rates of younger people were found in the 
“Constant Low” group with few SA/DP months at T-5.  
Also, socio-demographic factors were found to be risk markers for suicide attempt and 
suicide, including sex, age, education, and family situation in patients with depressive 
disorders (Study II). Female sex, young age, low and medium educational level, and being 
single without children living at home were risk markers of suicide attempt while living in 
small towns/villages was associated with a lower risk of suicide attempt among patients with 
depressive disorders. Male sex showed an excess risk of suicide while being 
married/cohabiting and having children living at home was a protective factor of suicide 
among patients with depressive disorders. These findings are in line with previous studies 
(182, 183). Still, the study on depressed patients in this thesis was based on a larger study 
population and had, therefore, more precise estimates than previous studies.  
Measures of morbidity, i.e., in- and specialised outpatient health care and previous suicide 
attempt, were found to be both associated with SA/DP trajectories prior to suicide (Study III) 
and being predictors of suicidal behaviour in depressed patients in Study II. In Study III, high 
proportions of long mental and somatic inpatient care stays and more frequent outpatient 
visits measured five years prior to suicide (T-5) were found both in the “Constant High” and 
“Increasing High” groups. These measures reflect the severity of the underlying somatic and 
mental disorders. Moreover, the “Decreasing” group had a high level of health care use at T-
5. The decreasing SA/DP months from T-5 to the year of suicide might reflect improvements 
in health conditions during the follow-up time. In Study II, inpatient care due to mental or 
somatic disorders was observed to be associated with a higher risk of subsequent suicide 
attempt and suicide among patients with depressive disorders compared to those without such 
care. Long hospital stays due to mental disorders may indicate a higher severity of the 
depressive disorder or another coexisting mental disorder, which has previously been shown 
to be associated with a higher risk of suicidal behaviour (83, 182). 
In contrast, in Study III the “Constant Low” and the “Increasing Low” groups included a 
larger proportion of individuals with less in- and specialised outpatient care at T-5. The few 
SA/DP months at T-5 in the “Increasing Low” group could be interpreted by better health 
conditions in terms of less in- or specialised outpatient health care five years prior to suicide. 
The increasing number of average months with SA/DP in the “Increasing Low” group might 
signal deteriorations in somatic or mental health, which is reflected in increasing work 
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incapacity. Regarding the “Constant Low” group, one possible explanation of the lower 
health care use is that the group also comprised a larger proportion of young men. Young 
men have been reported to have a higher threshold for reporting health complaints and are 
less prone to seek help than their female counterparts (172, 173). Young men have also been 
reported to have less frequent previous suicide attempts than females when they commit 
suicide (184). Still, in this “Constant Low” group 43.8% of the individuals had specialised 
outpatient visits due to somatic disorders at T-5. Also in Study II, higher HRs of suicide 
attempt among individuals with somatic inpatient care were found. These results may be 
explained by the psychosocial stress associated with the medical severity of the underlying 
somatic disorder or unmeasured underlying comorbid mental disorders, which may be 
associated with subsequent suicidal behaviour (119). 
Previous suicide attempt was found to be significantly associated with SA/DP trajectories 
prior to suicide in Study III and subsequent suicide attempt and suicide among patients with 
depressive disorders in Study II. These findings are consistent with previous studies showing 
higher risks of suicidal behaviour among depressed individuals with a history of attempted 
suicide than those without such a history (95, 104, 182, 183).  
Further, a higher risk of suicide attempt and suicide was observed among patients with 
depressive disorders who were prescribed antidepressants in combination with anxiolytics 
(Study II). Physicians use antidepressants to treat patients with depressive disorders and 
anxiety disorders (185). Supplementary medication with anxiolytics may be used to treat 
insomnia and anxiety (185). Depressive disorders are often comorbid with anxiety and this 
comorbidity also occurs in individuals with suicidal behaviour (185, 186). Therefore, the higher 
risk of suicidal behaviour in patients with depressive disorders in case of combined 
prescription of antidepressants and anxiolytics may not only reflect the severity of depressive 
symptoms but also acute anxiety.  
5.3 Methodological considerations 
There are different methodological aspects that can be discussed regarding this type of 
epidemiological studies.  
One such aspect is validity. The internal validity of a study can be violated by selection bias, 
information bias, or confounding (187). Selection bias refers to the fact when a proper 
randomised selection of individuals is not achieved and the sample is not representative for 
the population it is derived from (187). Selection bias is assumed to be low in the studies of 
this thesis since register data with national coverage was used including all people of working 
ages registered as living in Sweden, not a sample. However, information might be missing 
regarding some of the studied aspects in some of the used registers. For instance, around 20% 
of the diagnoses are missing for the visits in the specialised outpatient care derived from the 
National Patient Register in Sweden during the years 2001-2007 (167). According to a report 
on this, the rate of missing information on mental diagnoses varied between counties and was 
higher from private health care providers (167). Still, there is no reason to anticipate that 
individuals with a depressive disorder - that is, those building the study base of Study II - 
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represent a specific selection of individuals treated with these disorders in specialised 
outpatient health care in Sweden, as missing information is geographically randomly 
distributed.  
Another methodological aspect includes information bias, which refers to a misclassification 
of exposure or outcome measures (187). This misclassification can be differential and non-
differential. For exposure misclassification, differential misclassification can be assumed if 
the misclassification of the exposure is different between individuals with and without the 
outcome. In the contrary, non-differential misclassification is assumed if it is not related to 
the outcome. Same standards are used in the case of outcome misclassification.  
One typical form of differential misclassification is recall bias, which is not an issue when 
using register data, as in this thesis (187). Additionally, the quality of the Swedish registers is 
considered to be good (90, 188) minimising the risk of information bias. Still, misclassifications 
of sick-leave diagnoses have been discussed, however seldom studied. Physicians state the 
main diagnosis that has led to the impaired work capacity in terms of ICD-codes at the sick-
leave certificate. In some cases the information about diagnoses might not have been coded 
into ICD-codes by the physician, or has been difficult to read or scan at SIA, e.g. due to 
unreadable handwriting (189). Nevertheless, the validity of sick-leave diagnoses was evaluated 
in one study and showed acceptable validity (190). Moreover, missing information on sick-
leave diagnoses in the MiDAS database was observed, that is, the diagnoses on the sickness 
certificate was not included in MiDAS (around 15% of all sick-leave spells after 2004). This 
mainly occurred for the very short sick-leave spells. However, missing information on sick-
leave diagnoses in MiDAS appears to be randomly distributed across the different outcome 
measures and this misclassification is assumed to be non-differential. Furthermore, under-
reporting of sickness absence due to mental diagnoses may be possible. On the other hand, 
the validity of mental sick-leave diagnoses can be assumed to be good if considering the 
stigma still attached to mental disorders (191).  
In the data for this thesis, sick-leave spells <15 days were not included for  most of the 
employed individuals since information on sickness absence for these individuals is only 
available for day 15 and onwards from the SIA (2). In Study I and IV, sick-leave duration 1-
14 days mainly included unemployed individuals and individuals with some chronic diseases 
who might have higher risks of subsequent morbidity and suicidal behaviour. That means that 
risk estimates of sick-leave spells <15 days in relation to subsequent morbidity and suicidal 
behaviour in the studies might be overestimated.  
Data on suicide attempt and suicide were obtained from the National Patient Register and the 
Cause of Death Register, both held by the National Board of Health and Welfare. Information 
on main diagnoses and causes of death is missing in around 1% of the cases in these registers 
(84, 90). In Study I and II, information on suicide attempt and suicide with determined intent 
was used. In Study III and IV, a strategy of combining suicide attempt and suicide with 
determined and undetermined intent was applied when defining suicidal behaviour (92-94, 167). 
Sensitivity analyses by excluding suicidal behaviour with undetermined intent showed similar 
results. Under-reported or misclassified suicide attempts and suicides may still occur. The 
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distribution of under-reported or misclassified suicidal behaviour may in some cases differ in 
relation to the exposure measures and in that case estimates might have been under- or 
overestimated.   
A confounding variable is defined as being associated with both the exposure and the 
outcome and is not in the causal pathway between exposure and outcome (187). For this 
reason, confounders need to be taken into consideration in the analyses in order to estimate a 
relatively more accurate association. In the four studies, a number of potential confounders, 
including socio-demographic factors, inpatient and specialised outpatient care due to mental 
and somatic disorders, suicide attempt, and medication could be controlled for. Still, residual 
confounding is possible. For example, adjustment for psychiatric morbidity including 
information on antidepressant and/or anxiolytics prescription as well as specialised 
psychiatric health care does not capture all psychiatric morbidity. This means that 
information on psychiatric morbidity treated in primary health care, other prescription than 
antidepressants and anxiolytics and on morbidity which has not come to the attention of the 
health care system could not be controlled for in the analyses. Moreover, with regard to 
somatic morbidity only information on specialised health care was available. In addition, only 
previous suicide attempt from inpatient care was controlled for in the multivariate analyses. 
This can be seen both as a strength and as a limitation—a strength as the studies in this thesis 
captured the more serious cases. However, not all suicide attempters have been treated in 
inpatient care (85).  
External validity refers to the generalisability of a finding to the general population (187). The 
study populations for all the studies in this thesis were defined by using registers with 
nationwide coverage and included the whole working-aged population, not a sample. The 
studies in this thesis are therefore not selected with regard to e.g., specific regions or specific 
occupational groups. Therefore, the findings in this thesis can be generalised to working-aged 
individuals living in countries with comparable economic and labour market situation and 
health care and social insurance systems. Measures of morbidity have been conceptualised as 
inpatient and specialised outpatient care (in some cases as prescribed psychotropic drugs) in 
the studies in this thesis. In Study II, e.g., depressive disorders were measured by in- or 
specialised outpatient care due to these disorders. Findings in Study II can, therefore, be 
generalised to patients with these disorders treated in specialised health care in countries with 
comparable health care systems.  
5.4 Conclusions 
• All-cause sickness absence was associated with higher hazard ratios (HR) of subsequent 
suicide attempt and suicide among individuals of the general popuation as well as among 
patients with depressive disorders than among people without sickness absence. Although 
more women are usually granted sickness benefit, the risk of subsequent health 
outocomes and suicide mortality seems comparable for both women and men with 
sickness absence. Furthermore, higher HRs related to all-cause sickness absence were 
found regarding subsequent mental and somatic inpatient health care in the general 
population when comparing those with and without sickness absence. 
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• Sickness absence due to mental diagnoses was a risk marker for subsequent inpatient 
health care, suicide attempt, and suicide among women and men in the general population 
and both before and after the changes of social insurance regulations in 2008 in Sweden, 
as well as in patients with depressive disorders. Moreover, individuals with incident 
sickness absence due to mental dignoses in 2009 had higher HRs of subsequent inpatient 
care due to somatic disorders than individuals with such sickness absence in 2006. This 
might be related to differences in the severity of the underlying mental disorders in 
individuals on sickness absence before and after the regulatory changes in 2008 in 
Sweden. The new stricter rules may be related to the higher medical severity in 
individuals who were granted sickness benefit due to mental diagnoses after 2008.  
• Sickness absence due to somatic diagnoses was associated with higher HRs of subsequent 
inpatient health care, suicide attempt, and suicide among women and men in the general 
population (both before and after the regulatory changes in 2008) as well as in patients 
with depressive disorders compared with those without sickness absence. Specific 
somatic sick-leave diagnoses including musculoskeletal, injury, nervous, and circulatory 
disorders were associated with subsequent suicidal behaviour. Unmeasured and/or 
unrecognised mental disorders may underly these associations, highlighting the 
importance of the comorbidity of mental and somatic disorders.  
• Higher HRs of subsequent suicide attempt and suicide were found in relation to long 
sickness absence duration among women and men of the general popuation and patients 
with depressive disorders. Moreover, full-time sickness absence and more sick-leave 
spells were associated with higher HRs of subsequent suicide attempt among patients 
with depressive disorders. Individuals on long-term sickness absence after the regulatory 
changes in 2008 had higher risks of subsequent inpatient care due to somatic disorders 
than individuals with such sickness absence before the regulatory changes. This may 
reflect the new regulation in 2008 which introduced stricter rules for granting sickness 
absence and disability pension and a time limitation for sickness absence.  
• Among those who had committed suicide, five different trajectories of their sickness 
absence and disability pension (SA/DP) were identified during the five years before the 
suicide. Almost half of the study population had had constantly low levels of SA/DP, 
while 30% had constantly high levels of SA/DP before the suicide. These differences 
might be partly explained by the differences in socio-demographic and health care factors 
five years before suicide.  
• Several socio-demographic, health care, and medication factors were associated with the 
five different previous SA/DP trajectories among individuals who had committed suicide. 
In the study of patients with depressive disorders, these factors were also associated with 
future suicide attempt and suicide.  
5.5 Further research  
Since associations between diagnosis-specific sickness absence and subsequent inpatient care 
and suicidal behaviour were found, it would be fruitful to conduct in-depth analyses 
regarding health care, medication, and different social situations in further studies. This 
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should be done stratified for different groups and including also information on changes of 
such aspects over time. Information on severity as well as on comorbidity also needs to be 
included in such studies. Future studies would also benefit from having information on 
primary health care use, and from self-reported health conditions, use of medication etc., and 
life style factors. In this way, a better knowledge on the extent to which the diagnosis of 
sickness absence contributes to higher risk of future adverse health outcomes would be 
gained. Studies that differentiate the effect of having a specific disease from being sickness 
absent due to that disease are challenging to design; however, possibilities to do this need to 
be further explored. Future studies are also recommended to use, for instance, surveys to 
collect information which could not be included in the studies of this thesis, e.g. information 
on morbidity of individuals who did not seek or require treatment in specialised health care. 
Further, small sex differences and cohort differences were found regarding diagnosis-specific 
sickness absence and sick-leave duration with regard to subsequent suicidal behaviour and 
adverse health outcomes. There is a need of future studies to replicate these findings and 
investigate potential mechanisms between women and men and cohort differences in such 
associations. These studies should ideally have long follow-up periods in order to guarantee 
sufficient statistical power related to the analyses of rare outcomes like suicidal behaviour. 
Moreover, other statistical methods could be applied in order to elucidate potential period 
effects related to the new social insurance regulations. 
As different SA/DP trajectories were found before suicide, further investigations of such 
trajectories are needed. Potential differences with regard to SA/DP trajectories prior to 
suicide attempt or first diagnosis of specific mental disorders as compared to SA/DP 
trajectories prior to completed suicide could be addressed in further research.  
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